YangXH的个人主页 - 老虎社区

YangXH

YangXH

暂无个人介绍

IP属地：未知

428关注

8粉丝

0主题

0勋章

2022-01-02

[Like]

NIO delivered 91,429 vehicles in 2021 in total, increasing by 109.1% year-over-year

2022-01-01

Like

抱歉，原内容已删除

2021-12-22

Like

抱歉，原内容已删除

2021-12-12

又是一个坑。看谁往里跳。

Grab shares dropped another 9% in morning trading

2021-12-09

Thanks for sharing

昨夜今晨：疫苗利好再度传来！苹果续刷历史新高

2021-12-09

[强]

Apple shares rose nearly 2% to a new high

2021-11-14

Good news

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.

2021-11-14

Like

Apple: The Bear Argument, And Why It's Wrong

2021-10-28

👍

抱歉，原内容已删除

2021-10-17

Like

5 Stocks To Watch For October 15, 2021

2021-10-15

Like $Apple(AAPL)$

Apple shares rallied 0.8% in premarket trading

2021-10-12

👍

Apple iPhone Wait Times Are at Multiyear Highs. What It Means for Sales.

2021-10-09

Thanks for sharing.

抱歉，原内容已删除

2021-10-05

👍

抱歉，原内容已删除

2021-09-28

Thanks for sharing

抱歉，原内容已删除

2021-09-14

Like

抱歉，原内容已删除

2021-09-13

Like

抱歉，原内容已删除

2021-09-12

Buy the dip

Buy or Sell Apple Stock Ahead of iPhone Event?

2021-09-11

Ok

抱歉，原内容已删除

2021-09-08

buy$DiDi Global Inc.(DIDI)$

@Buy_Sell:🚀【9月7日】美股昨夜休市，港股今日高开，今天买什么？

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586332417338594","uuid":"3586332417338594","gmtCreate":1623238393493,"gmtModify":1627745419718,"name":"YangXH","pinyin":"yangxh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":428,"tweetSize":83,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.05","exceedPercentage":"80.05%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692567591,"gmtCreate":1641078490941,"gmtModify":1641078491110,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"[Like]&nbsp;","listText":"[Like]&nbsp;","text":"[Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692567591","repostId":"2200412074","repostType":4,"repost":{"id":"2200412074","kind":"news","pubTimestamp":1641022620,"share":"https://www.laohu8.com/m/news/2200412074?lang=&edition=full","pubTime":"2022-01-01 15:37","market":"us","language":"en","title":"NIO delivered 91,429 vehicles in 2021 in total, increasing by 109.1% year-over-year","url":"https://stock-news.laohu8.com/highlight/detail?id=2200412074","media":"GlobeNewswire","summary":"Company Achieved New Quarterly Record and Delivered a Total of 91,429 Vehicles in 2021NIO delivered 10,489 vehicles in December 2021, increasing by 49.7% year-over-yearNIO delivered 25,034 vehicles in","content":"<html><head></head><body><p><i>Company Achieved New Quarterly Record and Delivered a Total of 91,429 Vehicles in 2021</i></p><ul><li><b><i>NIO delivered 10,489 vehicles in December 2021, increasing by 49.7% year-over-year</i></b></li><li><b><i>NIO delivered 25,034 vehicles in the three months ended December 2021, increasing by 44.3% year-over-year</i></b></li><li><b><i>NIO delivered 91,429 vehicles in 2021 in total, increasing by 109.1% year-over-year</i></b></li><li><b><i>Cumulative deliveries of the ES8, ES6 and EC6 as of December 31, 2021 reached 167,070</i></b></li></ul><p>SHANGHAI, China, Jan. 01, 2022 (GLOBE NEWSWIRE) -- NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer and a leading company in the premium smart electric vehicle market, today announced its December, fourth quarter and full year 2021 delivery results.</p><p>NIO delivered 10,489 vehicles in December 2021, increasing by 49.7% year-over-year. The deliveries consisted of 2,782 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,939 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 2,768 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO delivered 25,034 vehicles in the fourth quarter of 2021, a new record-high quarterly delivery representing an increase of 44.3% year-over-year. NIO delivered 91,429 vehicles in 2021 in total, representing a strong increase of 109.1% year-over-year. As of December 31, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 167,070 vehicles.</p><p>On December 18, 2021, NIO held NIO Day 2021 in Suzhou and launched the ET5, a mid-size premium smart electric sedan, with deliveries expected to commence in September 2022. The pre-subsidy starting price of the ET5 is RMB328,000, or RMB258,000 with Battery as a Service (BaaS). In addition, the Company expects to begin the delivery of the ET7, a flagship premium smart electric sedan, in March 2022.</p><p>About NIO Inc.</p><p>NIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users. NIO designs, develops, jointly manufactures and sells premium smart electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS. NIO launched the ES8, a seven-seater flagship premium smart electric SUV in December 2017, and began deliveries of the ES8 in June 2018 and its variant, the six-seater ES8, in March 2019. NIO launched the ES6, a five-seater high-performance premium smart electric SUV, in December 2018, and began deliveries of the ES6 in June 2019. NIO launched the EC6, a five-seater premium smart electric coupe SUV, in December 2019, and began deliveries of the EC6 in September 2020. NIO launched the ET7, a flagship premium smart electric sedan, in January 2021. NIO launched the ET5, a mid-size premium smart electric sedan, in December 2021.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO delivered 91,429 vehicles in 2021 in total, increasing by 109.1% year-over-year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO delivered 91,429 vehicles in 2021 in total, increasing by 109.1% year-over-year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-01 15:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/nio-inc-provides-december-fourth-073700564.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Company Achieved New Quarterly Record and Delivered a Total of 91,429 Vehicles in 2021NIO delivered 10,489 vehicles in December 2021, increasing by 49.7% year-over-yearNIO delivered 25,034 vehicles in...</p>\n\n<a href=\"https://finance.yahoo.com/news/nio-inc-provides-december-fourth-073700564.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4539":"次新股","BK4504":"桥水持仓","BK4555":"新能源车","BK4526":"热门中概股","BK4209":"餐馆","BK4007":"制药","BK4183":"个人用品","BK4099":"汽车制造商","BK4532":"文艺复兴科技持仓","BK4509":"腾讯概念","BK4534":"瑞士信贷持仓","BK4531":"中概回港概念","BK4548":"巴美列捷福持仓","BK4191":"家用电器","NIO":"蔚来","BK4167":"医疗保健技术","BK4505":"高瓴资本持仓"},"source_url":"https://finance.yahoo.com/news/nio-inc-provides-december-fourth-073700564.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2200412074","content_text":"Company Achieved New Quarterly Record and Delivered a Total of 91,429 Vehicles in 2021NIO delivered 10,489 vehicles in December 2021, increasing by 49.7% year-over-yearNIO delivered 25,034 vehicles in the three months ended December 2021, increasing by 44.3% year-over-yearNIO delivered 91,429 vehicles in 2021 in total, increasing by 109.1% year-over-yearCumulative deliveries of the ES8, ES6 and EC6 as of December 31, 2021 reached 167,070SHANGHAI, China, Jan. 01, 2022 (GLOBE NEWSWIRE) -- NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer and a leading company in the premium smart electric vehicle market, today announced its December, fourth quarter and full year 2021 delivery results.NIO delivered 10,489 vehicles in December 2021, increasing by 49.7% year-over-year. The deliveries consisted of 2,782 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,939 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 2,768 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO delivered 25,034 vehicles in the fourth quarter of 2021, a new record-high quarterly delivery representing an increase of 44.3% year-over-year. NIO delivered 91,429 vehicles in 2021 in total, representing a strong increase of 109.1% year-over-year. As of December 31, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 167,070 vehicles.On December 18, 2021, NIO held NIO Day 2021 in Suzhou and launched the ET5, a mid-size premium smart electric sedan, with deliveries expected to commence in September 2022. The pre-subsidy starting price of the ET5 is RMB328,000, or RMB258,000 with Battery as a Service (BaaS). In addition, the Company expects to begin the delivery of the ET7, a flagship premium smart electric sedan, in March 2022.About NIO Inc.NIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users. NIO designs, develops, jointly manufactures and sells premium smart electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS. NIO launched the ES8, a seven-seater flagship premium smart electric SUV in December 2017, and began deliveries of the ES8 in June 2018 and its variant, the six-seater ES8, in March 2019. NIO launched the ES6, a five-seater high-performance premium smart electric SUV, in December 2018, and began deliveries of the ES6 in June 2019. NIO launched the EC6, a five-seater premium smart electric coupe SUV, in December 2019, and began deliveries of the EC6 in September 2020. NIO launched the ET7, a flagship premium smart electric sedan, in January 2021. NIO launched the ET5, a mid-size premium smart electric sedan, in December 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692229908,"gmtCreate":1641000710901,"gmtModify":1641000711026,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692229908","repostId":"1158843518","repostType":4,"isVote":1,"tweetType":1,"viewCount":2208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691300396,"gmtCreate":1640132342748,"gmtModify":1640132342906,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691300396","repostId":"1179885314","repostType":2,"isVote":1,"tweetType":1,"viewCount":2115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605785199,"gmtCreate":1639265033810,"gmtModify":1639265033928,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"又是一个坑。看谁往里跳。","listText":"又是一个坑。看谁往里跳。","text":"又是一个坑。看谁往里跳。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605785199","repostId":"1134450838","repostType":4,"repost":{"id":"1134450838","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639148939,"share":"https://www.laohu8.com/m/news/1134450838?lang=&edition=full","pubTime":"2021-12-10 23:08","market":"us","language":"en","title":"Grab shares dropped another 9% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1134450838","media":"Tiger Newspress","summary":"Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.","content":"<p>Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/963eb8dd73ce8daa0d852d63f0bcc276\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares dropped another 9% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares dropped another 9% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 23:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/963eb8dd73ce8daa0d852d63f0bcc276\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134450838","content_text":"Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602827948,"gmtCreate":1639008697068,"gmtModify":1639008697193,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Thanks for sharing&nbsp;","listText":"Thanks for sharing&nbsp;","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602827948","repostId":"1137331022","repostType":2,"repost":{"id":"1137331022","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639005672,"share":"https://www.laohu8.com/m/news/1137331022?lang=&edition=full","pubTime":"2021-12-09 07:21","market":"us","language":"zh","title":"昨夜今晨：疫苗利好再度传来！苹果续刷历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1137331022","media":"老虎资讯综合","summary":"摘要：美股三大指数小幅收涨，苹果续创历史新高；中概股多数上涨，雾芯科技收涨超21%；辉瑞公司宣布加强针疫苗可中和奥密克戎毒株；游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%>>>\n\n海外市场\n美股三大指","content":"<blockquote>\n <b>摘要：</b>美股三大指数小幅收涨，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>续创历史新高；中概股多数上涨，雾芯科技收涨超21%；<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>公司宣布加强针疫苗可中和奥密克戎毒株；<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>Q3净亏损同比扩大，盘后一度跌逾7%&gt;&gt;&gt;\n</blockquote>\n<p><b>海外市场</b></p>\n<p><b>美股三大指数小幅收涨，苹果续创收盘历史新高</b></p>\n<p>美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。</p>\n<p><b>热门中概股收盘大多走高，雾芯科技涨超21%</b></p>\n<p>中概股多数上涨，雾芯科技收涨超21%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>涨超13%，<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>涨超11%，<a href=\"https://laohu8.com/S/GOTU\">高途</a>涨超11%，<a href=\"https://laohu8.com/S/LUCKIN\">瑞幸咖啡</a>涨超9%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>涨超8%，<a href=\"https://laohu8.com/S/ZTO\">中通快递</a>涨近6%；中概新能源汽车中，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超5.8%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>涨2.1%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超1%。</p>\n<p><b>美油收高0.4%，布油上涨0.5%</b></p>\n<p>美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲<a href=\"https://laohu8.com/S/ICE\">洲际交易所</a>2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。</p>\n<p><b>黄金期货收高0.1%，并创一周来盘中最高价</b></p>\n<p>黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。</p>\n<p><b>欧股主要指数收跌，德国DAX30指数跌0.79%</b></p>\n<p>德国DAX30指数周三收跌0.79%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></a></p>\n<p>辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>摩根大通：2022年全球经济将全面复苏</b></a></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p><b>世卫组织：奥密克戎毒株将显著影响全球疫情</b></p>\n<p>世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。</p>\n<p><a href=\"https://laohu8.com/NW/2190693181\" target=\"_blank\"><b>全球芯片短缺问题未有起色，交付等待时长再创历史新高</b></a></p>\n<p>芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。</p>\n<p><a href=\"https://laohu8.com/NW/2190869550\" target=\"_blank\"><b>美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓</b></a><b></b></p>\n<p>美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>英国首相恢复居家工作建议 以遏制omicron传播</b></a></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p><b>公司新闻</b></p>\n<p><a href=\"https://laohu8.com/NW/2190931896\" target=\"_blank\"><b>苹果股价续刷历史新高，市值逼近3万亿美元</b></a></p>\n<p>周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。</p>\n<p><a href=\"https://laohu8.com/NW/1141082394\" target=\"_blank\"><b>飙涨近22%！电子烟龙头豪掷超30亿回购股票</b></a></p>\n<p>电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。</p>\n<p><a href=\"https://laohu8.com/NW/1124189543\" target=\"_blank\"><b>辉瑞：加强针疫苗可中和奥密克戎毒株</b></a></p>\n<p>辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。</p>\n<p><b><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>Evusheld疫苗获得美国食品药品监督管理局紧急使用授权</b></p>\n<p>周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。</p>\n<p><a href=\"https://laohu8.com/NW/2189667417\" target=\"_blank\"><b>谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行</b></a></p>\n<p>据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”</p>\n<p><a href=\"https://laohu8.com/NW/2189663059\" target=\"_blank\"><b>福特首款电动皮卡需求火爆，预订量接近20万辆</b></a></p>\n<p>据报道，<a href=\"https://laohu8.com/S/F\">福特汽车</a>证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。</p>\n<p><a href=\"https://laohu8.com/NW/2189527726\" target=\"_blank\"><b>英特尔CEO：供应链问题将持续至2023年</b></a></p>\n<p>英特尔和<a href=\"https://laohu8.com/S/ACN\">埃森哲</a>CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”</p>\n<p><a href=\"https://laohu8.com/NW/1131202578\" target=\"_blank\"><b>游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%</b></a></p>\n<p>财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。</p>\n<p><a href=\"https://laohu8.com/NW/1177663836\" target=\"_blank\"><b>UiPath&nbsp;2022财年第三季度净亏损同比扩大</b></a></p>\n<p>财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：疫苗利好再度传来！苹果续刷历史新高</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：疫苗利好再度传来！苹果续刷历史新高\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-09 07:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n <b>摘要：</b>美股三大指数小幅收涨，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>续创历史新高；中概股多数上涨，雾芯科技收涨超21%；<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>公司宣布加强针疫苗可中和奥密克戎毒株；<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>Q3净亏损同比扩大，盘后一度跌逾7%&gt;&gt;&gt;\n</blockquote>\n<p><b>海外市场</b></p>\n<p><b>美股三大指数小幅收涨，苹果续创收盘历史新高</b></p>\n<p>美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。</p>\n<p><b>热门中概股收盘大多走高，雾芯科技涨超21%</b></p>\n<p>中概股多数上涨，雾芯科技收涨超21%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>涨超13%，<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>涨超11%，<a href=\"https://laohu8.com/S/GOTU\">高途</a>涨超11%，<a href=\"https://laohu8.com/S/LUCKIN\">瑞幸咖啡</a>涨超9%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>涨超8%，<a href=\"https://laohu8.com/S/ZTO\">中通快递</a>涨近6%；中概新能源汽车中，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超5.8%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>涨2.1%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超1%。</p>\n<p><b>美油收高0.4%，布油上涨0.5%</b></p>\n<p>美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲<a href=\"https://laohu8.com/S/ICE\">洲际交易所</a>2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。</p>\n<p><b>黄金期货收高0.1%，并创一周来盘中最高价</b></p>\n<p>黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。</p>\n<p><b>欧股主要指数收跌，德国DAX30指数跌0.79%</b></p>\n<p>德国DAX30指数周三收跌0.79%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></a></p>\n<p>辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>摩根大通：2022年全球经济将全面复苏</b></a></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p><b>世卫组织：奥密克戎毒株将显著影响全球疫情</b></p>\n<p>世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。</p>\n<p><a href=\"https://laohu8.com/NW/2190693181\" target=\"_blank\"><b>全球芯片短缺问题未有起色，交付等待时长再创历史新高</b></a></p>\n<p>芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。</p>\n<p><a href=\"https://laohu8.com/NW/2190869550\" target=\"_blank\"><b>美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓</b></a><b></b></p>\n<p>美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>英国首相恢复居家工作建议 以遏制omicron传播</b></a></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p><b>公司新闻</b></p>\n<p><a href=\"https://laohu8.com/NW/2190931896\" target=\"_blank\"><b>苹果股价续刷历史新高，市值逼近3万亿美元</b></a></p>\n<p>周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。</p>\n<p><a href=\"https://laohu8.com/NW/1141082394\" target=\"_blank\"><b>飙涨近22%！电子烟龙头豪掷超30亿回购股票</b></a></p>\n<p>电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。</p>\n<p><a href=\"https://laohu8.com/NW/1124189543\" target=\"_blank\"><b>辉瑞：加强针疫苗可中和奥密克戎毒株</b></a></p>\n<p>辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。</p>\n<p><b><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>Evusheld疫苗获得美国食品药品监督管理局紧急使用授权</b></p>\n<p>周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。</p>\n<p><a href=\"https://laohu8.com/NW/2189667417\" target=\"_blank\"><b>谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行</b></a></p>\n<p>据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”</p>\n<p><a href=\"https://laohu8.com/NW/2189663059\" target=\"_blank\"><b>福特首款电动皮卡需求火爆，预订量接近20万辆</b></a></p>\n<p>据报道，<a href=\"https://laohu8.com/S/F\">福特汽车</a>证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。</p>\n<p><a href=\"https://laohu8.com/NW/2189527726\" target=\"_blank\"><b>英特尔CEO：供应链问题将持续至2023年</b></a></p>\n<p>英特尔和<a href=\"https://laohu8.com/S/ACN\">埃森哲</a>CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”</p>\n<p><a href=\"https://laohu8.com/NW/1131202578\" target=\"_blank\"><b>游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%</b></a></p>\n<p>财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。</p>\n<p><a href=\"https://laohu8.com/NW/1177663836\" target=\"_blank\"><b>UiPath&nbsp;2022财年第三季度净亏损同比扩大</b></a></p>\n<p>财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{"BK4501":"段永平概念","AAPL":"苹果","BK4532":"文艺复兴科技持仓",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4527":"明星科技股",".IXIC":"NASDAQ Composite","BK4534":"瑞士信贷持仓",".SPX":"S&P 500 Index","BK4507":"流媒体概念","BK4505":"高瓴资本持仓","BK4553":"喜马拉雅资本持仓","BK4554":"元宇宙及AR概念","BK4550":"红杉资本持仓","BK4559":"巴菲特持仓","BK4566":"资本集团","BK4515":"5G概念","BK4170":"电脑硬件、储存设备及电脑周边"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137331022","content_text":"摘要：美股三大指数小幅收涨，苹果续创历史新高；中概股多数上涨，雾芯科技收涨超21%；辉瑞公司宣布加强针疫苗可中和奥密克戎毒株；游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%>>>\n\n海外市场\n美股三大指数小幅收涨，苹果续创收盘历史新高\n美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。\n热门中概股收盘大多走高，雾芯科技涨超21%\n中概股多数上涨，雾芯科技收涨超21%，好未来涨超13%，贝壳涨超11%，高途涨超11%，瑞幸咖啡涨超9%，新东方涨超8%，中通快递涨近6%；中概新能源汽车中，蔚来涨超5.8%，理想汽车涨2.1%，小鹏汽车涨超1%。\n美油收高0.4%，布油上涨0.5%\n美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲洲际交易所2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。\n黄金期货收高0.1%，并创一周来盘中最高价\n黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。\n欧股主要指数收跌，德国DAX30指数跌0.79%\n德国DAX30指数周三收跌0.79%，英国富时100跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。\n国际宏观\n辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。\n摩根大通：2022年全球经济将全面复苏\n美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。\n世卫组织：奥密克戎毒株将显著影响全球疫情\n世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。\n全球芯片短缺问题未有起色，交付等待时长再创历史新高\n芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。\n美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓\n美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。\n英国首相恢复居家工作建议 以遏制omicron传播\n英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。\n公司新闻\n苹果股价续刷历史新高，市值逼近3万亿美元\n周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。\n飙涨近22%！电子烟龙头豪掷超30亿回购股票\n电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。\n辉瑞：加强针疫苗可中和奥密克戎毒株\n辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。\n阿斯利康Evusheld疫苗获得美国食品药品监督管理局紧急使用授权\n周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。\n谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行\n据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”\n福特首款电动皮卡需求火爆，预订量接近20万辆\n据报道，福特汽车证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。\n英特尔CEO：供应链问题将持续至2023年\n英特尔和埃森哲CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”\n游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%\n财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。\nUiPath 2022财年第三季度净亏损同比扩大\n财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602800962,"gmtCreate":1639003612096,"gmtModify":1639003705577,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"[强]&nbsp;","listText":"[强]&nbsp;","text":"[强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602800962","repostId":"1161444269","repostType":4,"repost":{"id":"1161444269","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638977215,"share":"https://www.laohu8.com/m/news/1161444269?lang=&edition=full","pubTime":"2021-12-08 23:26","market":"us","language":"en","title":"Apple shares rose nearly 2% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1161444269","media":"Tiger Newspress","summary":"Apple shares rose nearly 2% to a new high in morning trading.","content":"<p>Apple shares rose nearly 2% to a new high&nbsp;in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/9a9f5fdc1cb0a898675c515a39de7611\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose nearly 2% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose nearly 2% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose nearly 2% to a new high&nbsp;in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/9a9f5fdc1cb0a898675c515a39de7611\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161444269","content_text":"Apple shares rose nearly 2% to a new high in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873988440,"gmtCreate":1636843830814,"gmtModify":1636843830928,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Good news&nbsp;","listText":"Good news&nbsp;","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873988440","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873981731,"gmtCreate":1636843702976,"gmtModify":1636843703092,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873981731","repostId":"1129004768","repostType":4,"repost":{"id":"1129004768","kind":"news","pubTimestamp":1636764434,"share":"https://www.laohu8.com/m/news/1129004768?lang=&edition=full","pubTime":"2021-11-13 08:47","market":"us","language":"en","title":"Apple: The Bear Argument, And Why It's Wrong","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004768","media":"Seeking Alpha","summary":"Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.This may also help to explain, in part, why Apple's revenues in Greater China shot through the","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.</li>\n <li>I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.</li>\n <li>Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4bc955cc5d27328c3b89b327b9368d27\" tg-width=\"1536\" tg-height=\"1020\" width=\"100%\" height=\"auto\"><span>kmwphotography/iStock via Getty Images</span></p>\n<p>With Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.</p>\n<p>Below, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.</p>\n<p><b>Key risk #1: drop-off in demand</b></p>\n<p>Not many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's&nbsp;Pierre Ferragu&nbsp;and Satori Fund's&nbsp;Dan Niles&nbsp;are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.</p>\n<p>The first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder&nbsp;Steve Wozniak) see as merely a minor upgrade from the previous model.</p>\n<p>I see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7dc677f0a1c77dd39f40b4cc99c6fc15\" tg-width=\"460\" tg-height=\"322\" width=\"100%\" height=\"auto\"><span>Source: DM Martins Research, data from company reports</span></p>\n<p>This may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.</p>\n<p>In the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.</p>\n<p><b>Key risk #2: valuation</b></p>\n<p>The other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS&nbsp;to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.</p>\n<p>That, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.</p>\n<p>First, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer&nbsp;have been hurting social media companies&nbsp;and their financial statements&nbsp;led to the Nasdaqe&nbsp;rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0946db3f3bc62569a56f2dbe2aa75922\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Also, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.</p>\n<p><b>Key risk #3: lack of positive catalysts</b></p>\n<p>The next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and&nbsp;so has the refreshed lineup&nbsp;of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.</p>\n<p>But here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.</p>\n<p>I have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and&nbsp;autonomous vehicle&nbsp;has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.</p>\n<p><b>In summary</b></p>\n<p>Apple may not be the same pound-the-table opportunity that I believed it to be&nbsp;in February 2021&nbsp;or, better yet,in April 2018&nbsp;– in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: The Bear Argument, And Why It's Wrong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: The Bear Argument, And Why It's Wrong\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and ...</p>\n\n<a href=\"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129004768","content_text":"Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.\nMaybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.\n\nkmwphotography/iStock via Getty Images\nWith Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.\nBelow, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.\nKey risk #1: drop-off in demand\nNot many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's Pierre Ferragu and Satori Fund's Dan Niles are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.\nThe first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder Steve Wozniak) see as merely a minor upgrade from the previous model.\nI see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.\nSource: DM Martins Research, data from company reports\nThis may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.\nIn the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.\nKey risk #2: valuation\nThe other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.\nThat, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.\nFirst, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer have been hurting social media companies and their financial statements led to the Nasdaqe rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.\nData by YCharts\nAlso, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.\nKey risk #3: lack of positive catalysts\nThe next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and so has the refreshed lineup of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.\nBut here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.\nI have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and autonomous vehicle has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.\nIn summary\nApple may not be the same pound-the-table opportunity that I believed it to be in February 2021 or, better yet,in April 2018 – in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855675027,"gmtCreate":1635376050925,"gmtModify":1635377491227,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855675027","repostId":"2178234410","repostType":4,"isVote":1,"tweetType":1,"viewCount":1665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827145628,"gmtCreate":1634436722582,"gmtModify":1634436764081,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/827145628","repostId":"2175114209","repostType":4,"repost":{"id":"2175114209","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1634289865,"share":"https://www.laohu8.com/m/news/2175114209?lang=&edition=full","pubTime":"2021-10-15 17:24","market":"us","language":"en","title":"5 Stocks To Watch For October 15, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2175114209","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Goldman Sachs Group Inc  (NYSE: GS) to report quarterly earnings at $10.11 per share on revenue of $11.67 billion before the opening bell. Goldman Sachs shares gained 0.5% to $393.10 in pre-market trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b>Goldman Sachs Group Inc </b> (NYSE:GS) to report quarterly earnings at $10.11 per share on revenue of $11.67 billion before the opening bell. Goldman Sachs shares gained 0.5% to $393.10 in pre-market trading.</li>\n <li><b>Toyota Motor Corp </b>(NYSE:TM) slashed its global production target for November by 15% due to the pandemic-triggered parts crisis. Toyota cut the production target from 1 million units to 850,000 - 900,000 units. Toyota shares slipped 0.2% to close at $175.51 on Thursday.</li>\n <li>Analysts are expecting <b>J B Hunt Transport Services Inc </b> (NASDAQ:JBHT) to have earned $1.79 per share on revenue of $3.01 billion for the latest quarter. The company will release earnings before the markets open. J B Hunt Transport shares gained 2.3% to close at $175.24 on Thursday.</li>\n</ul>\n<ul>\n <li><b>Nio Inc - ADR</b> (NYSE:NIO) said it would be able to double annual production capacity at its Hefei facility in 2022, cnEVpost reported. Nio shares rose 1.6% to $36.85 in pre-market trading.</li>\n <li><b>Alcoa Corp</b> (NYSE:AA) reported better-than-expected results for its third quarter. The company announced a $500 million buyback program and initiated a quarterly dividend of $0.10 per share. Alcoa shares climbed 5% to $51.02 in pre-market trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For October 15, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For October 15, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-10-15 17:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b>Goldman Sachs Group Inc </b> (NYSE:GS) to report quarterly earnings at $10.11 per share on revenue of $11.67 billion before the opening bell. Goldman Sachs shares gained 0.5% to $393.10 in pre-market trading.</li>\n <li><b>Toyota Motor Corp </b>(NYSE:TM) slashed its global production target for November by 15% due to the pandemic-triggered parts crisis. Toyota cut the production target from 1 million units to 850,000 - 900,000 units. Toyota shares slipped 0.2% to close at $175.51 on Thursday.</li>\n <li>Analysts are expecting <b>J B Hunt Transport Services Inc </b> (NASDAQ:JBHT) to have earned $1.79 per share on revenue of $3.01 billion for the latest quarter. The company will release earnings before the markets open. J B Hunt Transport shares gained 2.3% to close at $175.24 on Thursday.</li>\n</ul>\n<ul>\n <li><b>Nio Inc - ADR</b> (NYSE:NIO) said it would be able to double annual production capacity at its Hefei facility in 2022, cnEVpost reported. Nio shares rose 1.6% to $36.85 in pre-market trading.</li>\n <li><b>Alcoa Corp</b> (NYSE:AA) reported better-than-expected results for its third quarter. The company announced a $500 million buyback program and initiated a quarterly dividend of $0.10 per share. Alcoa shares climbed 5% to $51.02 in pre-market trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JBHT":"JB Hunt运输服务","03160":"华夏日股对冲","GS":"高盛","NIO":"蔚来","TM":"丰田汽车","AA":"美国铝业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2175114209","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Goldman Sachs Group Inc  (NYSE:GS) to report quarterly earnings at $10.11 per share on revenue of $11.67 billion before the opening bell. Goldman Sachs shares gained 0.5% to $393.10 in pre-market trading.\nToyota Motor Corp (NYSE:TM) slashed its global production target for November by 15% due to the pandemic-triggered parts crisis. Toyota cut the production target from 1 million units to 850,000 - 900,000 units. Toyota shares slipped 0.2% to close at $175.51 on Thursday.\nAnalysts are expecting J B Hunt Transport Services Inc  (NASDAQ:JBHT) to have earned $1.79 per share on revenue of $3.01 billion for the latest quarter. The company will release earnings before the markets open. J B Hunt Transport shares gained 2.3% to close at $175.24 on Thursday.\n\n\nNio Inc - ADR (NYSE:NIO) said it would be able to double annual production capacity at its Hefei facility in 2022, cnEVpost reported. Nio shares rose 1.6% to $36.85 in pre-market trading.\nAlcoa Corp (NYSE:AA) reported better-than-expected results for its third quarter. The company announced a $500 million buyback program and initiated a quarterly dividend of $0.10 per share. Alcoa shares climbed 5% to $51.02 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1930,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824332460,"gmtCreate":1634278010141,"gmtModify":1634278010223,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like&nbsp;<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>","listText":"Like&nbsp;<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>","text":"Like $Apple(AAPL)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824332460","repostId":"1176807279","repostType":4,"repost":{"id":"1176807279","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634203027,"share":"https://www.laohu8.com/m/news/1176807279?lang=&edition=full","pubTime":"2021-10-14 17:17","market":"us","language":"en","title":"Apple shares rallied 0.8% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1176807279","media":"Tiger Newspress","summary":"Apple shares rallied 0.8% in premarket trading after Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple.Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple after reports that iPhone output might be hindered by the global chip shortage.Morgan Stanley analyst Katy Huberty on Wednesday urged investors to buy the dip in Apple despite reports that the tech giant may need to cut production of its signature iPhone 13 by as much as 10 million units due ","content":"<p>Apple shares rallied 0.8% in premarket trading&nbsp;after&nbsp;Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple.</p>\n<p><img src=\"https://static.tigerbbs.com/735b28a2fae1ded576148e22cba94a98\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple after reports that iPhone output might be hindered by the global chip shortage.</p>\n<p>Morgan Stanley analyst Katy Huberty on Wednesday urged investors to buy the dip in Apple&nbsp;despite&nbsp;reports that the tech giant may need to cut production of its signature iPhone 13 by as much as 10 million units due to the global chip shortage.</p>\n<p>\"We are buyers of any near-term Apple share price weakness on iPhone supply-chain disruption given Apple is likely to receive more supply than competitors, demand isn't perishable,\" Huberty wrote in a note.</p>\n<p>\"If Apple can't meet near-term demand, the shortfall is likely to be even greater at competitors, creating an opportunity for share gains,\" she wrote in a note published Wednesday.</p>\n<p>Shares of the Cupertino, Calif., company on&nbsp;Wednesday slipped 0.4% to $140.91.</p>\n<p>The investment firm maintained its overweight rating on the stock with a price target of $168 a share.</p>\n<p>\"While we have not specifically heard of material iPhone production bottlenecks due to semiconductor shortages at Broadcom&nbsp;or Texas Instruments, broader supply tightness continues to be a real issue across a number of end markets,\" she added.</p>\n<p>Broadcom and Texas Instruments are manufacturing partners for Apple.</p>\n<p>Apple had expected to produce 90 million new iPhone models in the last three months of the year.</p>\n<p>But it’s now telling manufacturing partners that the total will be lower because Broadcom and Texas Instruments are struggling to deliver enough components,Bloomberg reported, citing sources.</p>\n<p>\"Our FY22 estimates are unlikely to change materially even if revenue and EPS shift across quarters,\" she added.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rallied 0.8% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rallied 0.8% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-14 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rallied 0.8% in premarket trading&nbsp;after&nbsp;Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple.</p>\n<p><img src=\"https://static.tigerbbs.com/735b28a2fae1ded576148e22cba94a98\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple after reports that iPhone output might be hindered by the global chip shortage.</p>\n<p>Morgan Stanley analyst Katy Huberty on Wednesday urged investors to buy the dip in Apple&nbsp;despite&nbsp;reports that the tech giant may need to cut production of its signature iPhone 13 by as much as 10 million units due to the global chip shortage.</p>\n<p>\"We are buyers of any near-term Apple share price weakness on iPhone supply-chain disruption given Apple is likely to receive more supply than competitors, demand isn't perishable,\" Huberty wrote in a note.</p>\n<p>\"If Apple can't meet near-term demand, the shortfall is likely to be even greater at competitors, creating an opportunity for share gains,\" she wrote in a note published Wednesday.</p>\n<p>Shares of the Cupertino, Calif., company on&nbsp;Wednesday slipped 0.4% to $140.91.</p>\n<p>The investment firm maintained its overweight rating on the stock with a price target of $168 a share.</p>\n<p>\"While we have not specifically heard of material iPhone production bottlenecks due to semiconductor shortages at Broadcom&nbsp;or Texas Instruments, broader supply tightness continues to be a real issue across a number of end markets,\" she added.</p>\n<p>Broadcom and Texas Instruments are manufacturing partners for Apple.</p>\n<p>Apple had expected to produce 90 million new iPhone models in the last three months of the year.</p>\n<p>But it’s now telling manufacturing partners that the total will be lower because Broadcom and Texas Instruments are struggling to deliver enough components,Bloomberg reported, citing sources.</p>\n<p>\"Our FY22 estimates are unlikely to change materially even if revenue and EPS shift across quarters,\" she added.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176807279","content_text":"Apple shares rallied 0.8% in premarket trading after Morgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple.\n\nMorgan Stanley analyst Katy Huberty reiterated an overweight rating on Apple after reports that iPhone output might be hindered by the global chip shortage.\nMorgan Stanley analyst Katy Huberty on Wednesday urged investors to buy the dip in Apple despite reports that the tech giant may need to cut production of its signature iPhone 13 by as much as 10 million units due to the global chip shortage.\n\"We are buyers of any near-term Apple share price weakness on iPhone supply-chain disruption given Apple is likely to receive more supply than competitors, demand isn't perishable,\" Huberty wrote in a note.\n\"If Apple can't meet near-term demand, the shortfall is likely to be even greater at competitors, creating an opportunity for share gains,\" she wrote in a note published Wednesday.\nShares of the Cupertino, Calif., company on Wednesday slipped 0.4% to $140.91.\nThe investment firm maintained its overweight rating on the stock with a price target of $168 a share.\n\"While we have not specifically heard of material iPhone production bottlenecks due to semiconductor shortages at Broadcom or Texas Instruments, broader supply tightness continues to be a real issue across a number of end markets,\" she added.\nBroadcom and Texas Instruments are manufacturing partners for Apple.\nApple had expected to produce 90 million new iPhone models in the last three months of the year.\nBut it’s now telling manufacturing partners that the total will be lower because Broadcom and Texas Instruments are struggling to deliver enough components,Bloomberg reported, citing sources.\n\"Our FY22 estimates are unlikely to change materially even if revenue and EPS shift across quarters,\" she added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826356956,"gmtCreate":1633993303711,"gmtModify":1633993303822,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826356956","repostId":"1178640662","repostType":4,"repost":{"id":"1178640662","kind":"news","pubTimestamp":1633963601,"share":"https://www.laohu8.com/m/news/1178640662?lang=&edition=full","pubTime":"2021-10-11 22:46","market":"us","language":"en","title":"Apple iPhone Wait Times Are at Multiyear Highs. What It Means for Sales.","url":"https://stock-news.laohu8.com/highlight/detail?id=1178640662","media":"Barrons","summary":"If you want to buy the new iPhone, you’re going to have to wait a while. Usually that would be a goo","content":"<p></p>\n<p>If you want to buy the new iPhone, you’re going to have to wait a while. Usually that would be a good sign for Apple stock, but the picture is a bit more complicated this year.</p>\n<p>Wait times for the iPhone 13 family of devices remain extended across the board, analysts at&nbsp;Credit Suisse&nbsp;said Friday. Customers who want the iPhone 13 Pro and Pro Max have to wait more than four weeks, which is the longest in at least four years, the team at the Swiss bank said.</p>\n<p>For the iPhone 13, the wait time is also long at two to four weeks, the analysts noted, with wait times remaining similar or even growing modestly longer between Sept. 4 and Sept. 8.</p>\n<p>The analysts’ methodology for calculating waiting periods involves measuring shipping lead times for iPhones purchased directly from Apple online in major markets around the world. They exclude demand through Apple’s physical stores as well as distribution through carriers and other retail outlets.</p>\n<p>Wait times have in the past been viewed as an indicator of demand for devices, which would suggest the iPhone 13 is headed for blowout sales. That would be good for Apple investors, because, as <i>Barron’s</i> reporter Max A. Cherney wrote last month, “Apple stock practically lives and dies on the company’s iPhone sales every year.”</p>\n<p>But this year, in a world gripped by supply-chain issues, wait times for some models being at multiyear records might not be the clear green flag it would have been in the past.</p>\n<p>“We’d highlight that while wait times are a rough proxy for initial demand, the metric is only one of many variables impacting iPhone sell-through; supply availability is a key unknown, particularly this year,” the analysts said.</p>\n<p>They added that it was “encouraging” to see wait times for the more expensive higher-end models such as the Pro and Pro Max remaining most extended, but that supply likely also plays a critical role in longer waits. This makes it even more difficult to analyze underlying demand for the iPhone 13 family.</p>\n<p>Credit Suisse has a price target of $150 on&nbsp;Apple&nbsp;(ticker: AAPL) stock, which was trading hands around $142 Monday. The company’s shares fell 0.6% when trading began this week.</p>\n<p>Apple has been approached for comment.</p>\n<p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple iPhone Wait Times Are at Multiyear Highs. What It Means for Sales.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple iPhone Wait Times Are at Multiyear Highs. What It Means for Sales.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-11 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-iphone-wait-times-multiyear-highs-51633962094?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you want to buy the new iPhone, you’re going to have to wait a while. Usually that would be a good sign for Apple stock, but the picture is a bit more complicated this year.\nWait times for the ...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-iphone-wait-times-multiyear-highs-51633962094?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.barrons.com/articles/apple-iphone-wait-times-multiyear-highs-51633962094?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178640662","content_text":"If you want to buy the new iPhone, you’re going to have to wait a while. Usually that would be a good sign for Apple stock, but the picture is a bit more complicated this year.\nWait times for the iPhone 13 family of devices remain extended across the board, analysts at Credit Suisse said Friday. Customers who want the iPhone 13 Pro and Pro Max have to wait more than four weeks, which is the longest in at least four years, the team at the Swiss bank said.\nFor the iPhone 13, the wait time is also long at two to four weeks, the analysts noted, with wait times remaining similar or even growing modestly longer between Sept. 4 and Sept. 8.\nThe analysts’ methodology for calculating waiting periods involves measuring shipping lead times for iPhones purchased directly from Apple online in major markets around the world. They exclude demand through Apple’s physical stores as well as distribution through carriers and other retail outlets.\nWait times have in the past been viewed as an indicator of demand for devices, which would suggest the iPhone 13 is headed for blowout sales. That would be good for Apple investors, because, as Barron’s reporter Max A. Cherney wrote last month, “Apple stock practically lives and dies on the company’s iPhone sales every year.”\nBut this year, in a world gripped by supply-chain issues, wait times for some models being at multiyear records might not be the clear green flag it would have been in the past.\n“We’d highlight that while wait times are a rough proxy for initial demand, the metric is only one of many variables impacting iPhone sell-through; supply availability is a key unknown, particularly this year,” the analysts said.\nThey added that it was “encouraging” to see wait times for the more expensive higher-end models such as the Pro and Pro Max remaining most extended, but that supply likely also plays a critical role in longer waits. This makes it even more difficult to analyze underlying demand for the iPhone 13 family.\nCredit Suisse has a price target of $150 on Apple (ticker: AAPL) stock, which was trading hands around $142 Monday. The company’s shares fell 0.6% when trading began this week.\nApple has been approached for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821633938,"gmtCreate":1633738598329,"gmtModify":1633738598517,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Thanks for sharing.&nbsp;","listText":"Thanks for sharing.&nbsp;","text":"Thanks for sharing.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821633938","repostId":"2173926948","repostType":4,"isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820600301,"gmtCreate":1633387291035,"gmtModify":1633387291255,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820600301","repostId":"1144613093","repostType":4,"isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866654165,"gmtCreate":1632780229357,"gmtModify":1632797972996,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Thanks for sharing&nbsp;","listText":"Thanks for sharing&nbsp;","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866654165","repostId":"2170623235","repostType":4,"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":886837710,"gmtCreate":1631579401130,"gmtModify":1631888928536,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/886837710","repostId":"1171919128","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888863222,"gmtCreate":1631488299666,"gmtModify":1631888928539,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888863222","repostId":"2166377772","repostType":4,"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888087240,"gmtCreate":1631413863580,"gmtModify":1631888928544,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Buy the dip","listText":"Buy the dip","text":"Buy the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888087240","repostId":"1101906502","repostType":4,"repost":{"id":"1101906502","kind":"news","pubTimestamp":1631407634,"share":"https://www.laohu8.com/m/news/1101906502?lang=&edition=full","pubTime":"2021-09-12 08:47","market":"us","language":"en","title":"Buy or Sell Apple Stock Ahead of iPhone Event?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101906502","media":"TheStreet","summary":"Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.Shares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.On Sept. 14, the company will hold a virtual event to introduce the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.However, Apple remains in the news for other reas","content":"<p>Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.</p>\n<p>Shares of Apple&nbsp;Report&nbsp;fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.</p>\n<p>On Sept. 14, the company will&nbsp;hold a virtual event to introduce&nbsp;the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.</p>\n<p>However, Apple remains in the news for other reasons, too.</p>\n<p>After hitting new highs earlier this week, the stock declined Friday after news of a court ruling&nbsp;in its case with Epic Games.</p>\n<p>That’s alongside a report that was published by well-known Morgan Stanley analyst Katy Huberty, who made the case that Apple stock&nbsp;is “compelling” ahead of its upcoming event.</p>\n<p>Like I said, it’s a lot of information for investors to digest. Let’s take a look at how the charts are setting up.</p>\n<p><b>Trading Apple Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd94f6dcfc32af44a4ae542425f3c92f\" tg-width=\"700\" tg-height=\"429\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p>\n<p>Each time Apple has reported earnings this year, it has resulted in a selloff. Unfortunately, those selloffs would come right as the stock was at or near all-time highs. Those events are marked on the chart with blue arrows.</p>\n<p>It was even more frustrating that Apple&nbsp;blew out analysts’ expectations each time, yet the stock sold off anyway.</p>\n<p>However, rather than a massive dip following the most recent report, the stock only pulled back to the $145 area, near the prior high. It also held the 21-day moving average as support.</p>\n<p>The stock has since pushed up through $150 and earlier this week, hit new all-time highs.</p>\n<p>For now, we’re getting a dip back down to the key $150 area and the 21-day moving average. Aggressive bulls can buy this dip ahead of the company’s event on Tuesday.</p>\n<p>If we break Friday’s low, investors may consider stopping out of the trade and buying on a potentially larger dip down to the 50-day moving average or the $145 area.</p>\n<p>Below $145 may put the $138 level and the 200-day moving average in play.</p>\n<p>Should Apple trade up through the all-time high at $157.26, the 161.8% extension is in play up near $160. Above that mark could put the $172 to $175 zone on the table, depending on how investors react to the event.</p>\n<p>For what it’s worth, September is by far Apple’s worst-performing month, up just three of the last 11 years for the month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy or Sell Apple Stock Ahead of iPhone Event?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy or Sell Apple Stock Ahead of iPhone Event?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.\nShares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as ...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101906502","content_text":"Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.\nShares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.\nOn Sept. 14, the company will hold a virtual event to introduce the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.\nHowever, Apple remains in the news for other reasons, too.\nAfter hitting new highs earlier this week, the stock declined Friday after news of a court ruling in its case with Epic Games.\nThat’s alongside a report that was published by well-known Morgan Stanley analyst Katy Huberty, who made the case that Apple stock is “compelling” ahead of its upcoming event.\nLike I said, it’s a lot of information for investors to digest. Let’s take a look at how the charts are setting up.\nTrading Apple Stock\nDaily chart of Apple stock.\nEach time Apple has reported earnings this year, it has resulted in a selloff. Unfortunately, those selloffs would come right as the stock was at or near all-time highs. Those events are marked on the chart with blue arrows.\nIt was even more frustrating that Apple blew out analysts’ expectations each time, yet the stock sold off anyway.\nHowever, rather than a massive dip following the most recent report, the stock only pulled back to the $145 area, near the prior high. It also held the 21-day moving average as support.\nThe stock has since pushed up through $150 and earlier this week, hit new all-time highs.\nFor now, we’re getting a dip back down to the key $150 area and the 21-day moving average. Aggressive bulls can buy this dip ahead of the company’s event on Tuesday.\nIf we break Friday’s low, investors may consider stopping out of the trade and buying on a potentially larger dip down to the 50-day moving average or the $145 area.\nBelow $145 may put the $138 level and the 200-day moving average in play.\nShould Apple trade up through the all-time high at $157.26, the 161.8% extension is in play up near $160. Above that mark could put the $172 to $175 zone on the table, depending on how investors react to the event.\nFor what it’s worth, September is by far Apple’s worst-performing month, up just three of the last 11 years for the month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881899856,"gmtCreate":1631321584075,"gmtModify":1631888928548,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/881899856","repostId":"2166711943","repostType":4,"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880694514,"gmtCreate":1631053025138,"gmtModify":1631883892861,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"buy<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>","listText":"buy<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>","text":"buy$DiDi Global Inc.(DIDI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/880694514","repostId":"817455241","repostType":1,"repost":{"id":817455241,"gmtCreate":1630982859979,"gmtModify":1734394412956,"author":{"id":"3527667596890271","authorId":"3527667596890271","name":"Buy_Sell","avatar":"https://static.tigerbbs.com/a5f0ed79a338c758a22e0b4ea13bf9d2","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667596890271","authorIdStr":"3527667596890271"},"themes":[],"title":"🚀【9月7日】美股昨夜休市，港股今日高开，今天买什么？","htmlText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 9月7日讯，港股三大指数集体高开，恒指涨0.17%报26207点，国指涨0.16%报9386点，恒生科技指数涨0.52%报6814点。盘面上，国内煤炭期货开盘大涨，<a target=\"_blank\" href=\"https://laohu8.com/S/01898\">$中煤能源(01898)$</a> 高开1.75%，<a target=\"_blank\" href=\"https://laohu8.com/S/01088\">$中国神华(01088)$</a> 涨0.9%；内房股、铝业股表现强势，<a target=\"_blank\" href=\"https://laohu8.com/S/02600\">$中国铝业(02600)$</a> 涨超2%；深圳前海合作区大扩容，<a target=\"_blank\" href=\"https://laohu8.com/S/00152\">$深圳国际(00152)$</a> 涨近4%，深圳控股涨超3%；大型科技股普涨，<a target=\"_blank\" href=\"https://laohu8.com/S/03690\">$美团-W(03690)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09888\">$百度集团-SW(09888)$</a> 涨1.4%，腾讯涨1%，<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 小幅高开；生物医药下跌明显，电力","listText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 9月7日讯，港股三大指数集体高开，恒指涨0.17%报26207点，国指涨0.16%报9386点，恒生科技指数涨0.52%报6814点。盘面上，国内煤炭期货开盘大涨，<a target=\"_blank\" href=\"https://laohu8.com/S/01898\">$中煤能源(01898)$</a> 高开1.75%，<a target=\"_blank\" href=\"https://laohu8.com/S/01088\">$中国神华(01088)$</a> 涨0.9%；内房股、铝业股表现强势，<a target=\"_blank\" href=\"https://laohu8.com/S/02600\">$中国铝业(02600)$</a> 涨超2%；深圳前海合作区大扩容，<a target=\"_blank\" href=\"https://laohu8.com/S/00152\">$深圳国际(00152)$</a> 涨近4%，深圳控股涨超3%；大型科技股普涨，<a target=\"_blank\" href=\"https://laohu8.com/S/03690\">$美团-W(03690)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09888\">$百度集团-SW(09888)$</a> 涨1.4%，腾讯涨1%，<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 小幅高开；生物医药下跌明显，电力","text":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 9月7日讯，港股三大指数集体高开，恒指涨0.17%报26207点，国指涨0.16%报9386点，恒生科技指数涨0.52%报6814点。盘面上，国内煤炭期货开盘大涨，$中煤能源(01898)$ 高开1.75%，$中国神华(01088)$ 涨0.9%；内房股、铝业股表现强势，$中国铝业(02600)$ 涨超2%；深圳前海合作区大扩容，$深圳国际(00152)$ 涨近4%，深圳控股涨超3%；大型科技股普涨，$美团-W(03690)$ 、$百度集团-SW(09888)$ 涨1.4%，腾讯涨1%，$阿里巴巴-SW(09988)$ 、$京东集团-SW(09618)$ 小幅高开；生物医药下跌明显，电力","images":[{"img":"https://static.tigerbbs.com/8eb78770aab19e4545f8e5f25ed9867a","width":"299","height":"168"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/817455241","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":804815808,"gmtCreate":1627949568704,"gmtModify":1631891880889,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/804815808","repostId":"1183793139","repostType":4,"repost":{"id":"1183793139","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627914562,"share":"https://www.laohu8.com/m/news/1183793139?lang=&edition=full","pubTime":"2021-08-02 22:29","market":"us","language":"en","title":"Semiconductor stocks rally after ON Semi's strong earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1183793139","media":"Tiger Newspress","summary":"(August 2) The Philadelphia Semiconductor Index is up 1.6%, outperforming the 0.3% gain for the broa","content":"<p>(August 2)&nbsp;The Philadelphia Semiconductor Index is up 1.6%, outperforming the 0.3% gain for the broader tech sector (NYSEARCA:XLK) after chipmaker ON Semiconductor (NASDAQ:ON) reported strong earnings and an upside forecast despite the continuing supply chain constraints.</p>\n<p>ON Semiconductor stock surges over&nbsp;14%&nbsp;after record earnings that beat expectations, upbeat outlook.</p>\n<p>Shares of <a href=\"https://laohu8.com/S/ON\">ON Semiconductor Corp.</a> (ON) shot up over&nbsp;14% in morning trading Monday, after the chipmaker reported record adjusted profit and revenue that beat expectations and provided an upbeat outlook, citing accelerating demand in the automotive and industrial end markets.</p>\n<ul>\n <li>Net income was $184.1 million, or 42 cents a share, after a loss of $1.4 billion, or roughly breakeven on a per-share basis, in the year-ago period.</li>\n <li>Excluding nonrecurring items, adjusted earnings per share increased to a record 63 cents from 12 cents, beating the FactSet consensus of 49 cents.</li>\n <li>Revenue grew 37.6% to $1.67 billion, above the FactSet consensus of $1.62 billion.</li>\n <li>For the third quarter, the company expects adjusted EPS of 68 cents to 80 cents and revenue of $1.66 billion to $1.76 billion, above the FactSet consensus for EPS of 51 cents and revenue of $1.61 billion.</li>\n <li>Gross margin is expected to improve to 38.8% to 40.9% in the third quarter from 38.3% in the second quarter.</li>\n</ul>\n<p>The stock has rallied 19.3% year to date through Friday, while the PHLX Semiconductor Index has run up 20.1% and the S&amp;P 500 has advanced 17.0%.</p>\n<p>MKM Partners notes that ON called out \"accelerating demand for the auto and industrial end markets\" even as the global chip shortage continues.</p>\n<p>Top semiconductor gainers include ON's auto chip peers Microchip (MCHP +3.3%) and NXP Semiconductors (NXPI +2.6%) with the latter reporting earnings today after the bell. Semiconductor equipment players Applied Materials (AMAT +3.2%) and Lam Research (LRCX +2.0%) are also among the top tech gainers.</p>\n<p>Silicon Labs (SLAB +4.2%) continues to rally after announcing plans for a $1B modified Dutch auction.</p>\n<p><img src=\"https://static.tigerbbs.com/29705170f6277ecc6c92943d45c08bb7\" tg-width=\"315\" tg-height=\"412\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks rally after ON Semi's strong earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks rally after ON Semi's strong earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-02 22:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(August 2)&nbsp;The Philadelphia Semiconductor Index is up 1.6%, outperforming the 0.3% gain for the broader tech sector (NYSEARCA:XLK) after chipmaker ON Semiconductor (NASDAQ:ON) reported strong earnings and an upside forecast despite the continuing supply chain constraints.</p>\n<p>ON Semiconductor stock surges over&nbsp;14%&nbsp;after record earnings that beat expectations, upbeat outlook.</p>\n<p>Shares of <a href=\"https://laohu8.com/S/ON\">ON Semiconductor Corp.</a> (ON) shot up over&nbsp;14% in morning trading Monday, after the chipmaker reported record adjusted profit and revenue that beat expectations and provided an upbeat outlook, citing accelerating demand in the automotive and industrial end markets.</p>\n<ul>\n <li>Net income was $184.1 million, or 42 cents a share, after a loss of $1.4 billion, or roughly breakeven on a per-share basis, in the year-ago period.</li>\n <li>Excluding nonrecurring items, adjusted earnings per share increased to a record 63 cents from 12 cents, beating the FactSet consensus of 49 cents.</li>\n <li>Revenue grew 37.6% to $1.67 billion, above the FactSet consensus of $1.62 billion.</li>\n <li>For the third quarter, the company expects adjusted EPS of 68 cents to 80 cents and revenue of $1.66 billion to $1.76 billion, above the FactSet consensus for EPS of 51 cents and revenue of $1.61 billion.</li>\n <li>Gross margin is expected to improve to 38.8% to 40.9% in the third quarter from 38.3% in the second quarter.</li>\n</ul>\n<p>The stock has rallied 19.3% year to date through Friday, while the PHLX Semiconductor Index has run up 20.1% and the S&amp;P 500 has advanced 17.0%.</p>\n<p>MKM Partners notes that ON called out \"accelerating demand for the auto and industrial end markets\" even as the global chip shortage continues.</p>\n<p>Top semiconductor gainers include ON's auto chip peers Microchip (MCHP +3.3%) and NXP Semiconductors (NXPI +2.6%) with the latter reporting earnings today after the bell. Semiconductor equipment players Applied Materials (AMAT +3.2%) and Lam Research (LRCX +2.0%) are also among the top tech gainers.</p>\n<p>Silicon Labs (SLAB +4.2%) continues to rally after announcing plans for a $1B modified Dutch auction.</p>\n<p><img src=\"https://static.tigerbbs.com/29705170f6277ecc6c92943d45c08bb7\" tg-width=\"315\" tg-height=\"412\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183793139","content_text":"(August 2) The Philadelphia Semiconductor Index is up 1.6%, outperforming the 0.3% gain for the broader tech sector (NYSEARCA:XLK) after chipmaker ON Semiconductor (NASDAQ:ON) reported strong earnings and an upside forecast despite the continuing supply chain constraints.\nON Semiconductor stock surges over 14% after record earnings that beat expectations, upbeat outlook.\nShares of ON Semiconductor Corp. (ON) shot up over 14% in morning trading Monday, after the chipmaker reported record adjusted profit and revenue that beat expectations and provided an upbeat outlook, citing accelerating demand in the automotive and industrial end markets.\n\nNet income was $184.1 million, or 42 cents a share, after a loss of $1.4 billion, or roughly breakeven on a per-share basis, in the year-ago period.\nExcluding nonrecurring items, adjusted earnings per share increased to a record 63 cents from 12 cents, beating the FactSet consensus of 49 cents.\nRevenue grew 37.6% to $1.67 billion, above the FactSet consensus of $1.62 billion.\nFor the third quarter, the company expects adjusted EPS of 68 cents to 80 cents and revenue of $1.66 billion to $1.76 billion, above the FactSet consensus for EPS of 51 cents and revenue of $1.61 billion.\nGross margin is expected to improve to 38.8% to 40.9% in the third quarter from 38.3% in the second quarter.\n\nThe stock has rallied 19.3% year to date through Friday, while the PHLX Semiconductor Index has run up 20.1% and the S&P 500 has advanced 17.0%.\nMKM Partners notes that ON called out \"accelerating demand for the auto and industrial end markets\" even as the global chip shortage continues.\nTop semiconductor gainers include ON's auto chip peers Microchip (MCHP +3.3%) and NXP Semiconductors (NXPI +2.6%) with the latter reporting earnings today after the bell. Semiconductor equipment players Applied Materials (AMAT +3.2%) and Lam Research (LRCX +2.0%) are also among the top tech gainers.\nSilicon Labs (SLAB +4.2%) continues to rally after announcing plans for a $1B modified Dutch auction.","news_type":1},"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891810339,"gmtCreate":1628377591321,"gmtModify":1631891880817,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like and follow","listText":"Like and follow","text":"Like and follow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/891810339","repostId":"1180025090","repostType":4,"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888863222,"gmtCreate":1631488299666,"gmtModify":1631888928539,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888863222","repostId":"2166377772","repostType":4,"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888087240,"gmtCreate":1631413863580,"gmtModify":1631888928544,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Buy the dip","listText":"Buy the dip","text":"Buy the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888087240","repostId":"1101906502","repostType":4,"repost":{"id":"1101906502","kind":"news","pubTimestamp":1631407634,"share":"https://www.laohu8.com/m/news/1101906502?lang=&edition=full","pubTime":"2021-09-12 08:47","market":"us","language":"en","title":"Buy or Sell Apple Stock Ahead of iPhone Event?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101906502","media":"TheStreet","summary":"Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.Shares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.On Sept. 14, the company will hold a virtual event to introduce the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.However, Apple remains in the news for other reas","content":"<p>Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.</p>\n<p>Shares of Apple&nbsp;Report&nbsp;fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.</p>\n<p>On Sept. 14, the company will&nbsp;hold a virtual event to introduce&nbsp;the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.</p>\n<p>However, Apple remains in the news for other reasons, too.</p>\n<p>After hitting new highs earlier this week, the stock declined Friday after news of a court ruling&nbsp;in its case with Epic Games.</p>\n<p>That’s alongside a report that was published by well-known Morgan Stanley analyst Katy Huberty, who made the case that Apple stock&nbsp;is “compelling” ahead of its upcoming event.</p>\n<p>Like I said, it’s a lot of information for investors to digest. Let’s take a look at how the charts are setting up.</p>\n<p><b>Trading Apple Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd94f6dcfc32af44a4ae542425f3c92f\" tg-width=\"700\" tg-height=\"429\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p>\n<p>Each time Apple has reported earnings this year, it has resulted in a selloff. Unfortunately, those selloffs would come right as the stock was at or near all-time highs. Those events are marked on the chart with blue arrows.</p>\n<p>It was even more frustrating that Apple&nbsp;blew out analysts’ expectations each time, yet the stock sold off anyway.</p>\n<p>However, rather than a massive dip following the most recent report, the stock only pulled back to the $145 area, near the prior high. It also held the 21-day moving average as support.</p>\n<p>The stock has since pushed up through $150 and earlier this week, hit new all-time highs.</p>\n<p>For now, we’re getting a dip back down to the key $150 area and the 21-day moving average. Aggressive bulls can buy this dip ahead of the company’s event on Tuesday.</p>\n<p>If we break Friday’s low, investors may consider stopping out of the trade and buying on a potentially larger dip down to the 50-day moving average or the $145 area.</p>\n<p>Below $145 may put the $138 level and the 200-day moving average in play.</p>\n<p>Should Apple trade up through the all-time high at $157.26, the 161.8% extension is in play up near $160. Above that mark could put the $172 to $175 zone on the table, depending on how investors react to the event.</p>\n<p>For what it’s worth, September is by far Apple’s worst-performing month, up just three of the last 11 years for the month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy or Sell Apple Stock Ahead of iPhone Event?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy or Sell Apple Stock Ahead of iPhone Event?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.\nShares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as ...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101906502","content_text":"Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.\nShares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.\nOn Sept. 14, the company will hold a virtual event to introduce the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.\nHowever, Apple remains in the news for other reasons, too.\nAfter hitting new highs earlier this week, the stock declined Friday after news of a court ruling in its case with Epic Games.\nThat’s alongside a report that was published by well-known Morgan Stanley analyst Katy Huberty, who made the case that Apple stock is “compelling” ahead of its upcoming event.\nLike I said, it’s a lot of information for investors to digest. Let’s take a look at how the charts are setting up.\nTrading Apple Stock\nDaily chart of Apple stock.\nEach time Apple has reported earnings this year, it has resulted in a selloff. Unfortunately, those selloffs would come right as the stock was at or near all-time highs. Those events are marked on the chart with blue arrows.\nIt was even more frustrating that Apple blew out analysts’ expectations each time, yet the stock sold off anyway.\nHowever, rather than a massive dip following the most recent report, the stock only pulled back to the $145 area, near the prior high. It also held the 21-day moving average as support.\nThe stock has since pushed up through $150 and earlier this week, hit new all-time highs.\nFor now, we’re getting a dip back down to the key $150 area and the 21-day moving average. Aggressive bulls can buy this dip ahead of the company’s event on Tuesday.\nIf we break Friday’s low, investors may consider stopping out of the trade and buying on a potentially larger dip down to the 50-day moving average or the $145 area.\nBelow $145 may put the $138 level and the 200-day moving average in play.\nShould Apple trade up through the all-time high at $157.26, the 161.8% extension is in play up near $160. Above that mark could put the $172 to $175 zone on the table, depending on how investors react to the event.\nFor what it’s worth, September is by far Apple’s worst-performing month, up just three of the last 11 years for the month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899398088,"gmtCreate":1628157428944,"gmtModify":1631891880853,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899398088","repostId":"1119138550","repostType":4,"repost":{"id":"1119138550","kind":"news","pubTimestamp":1628157065,"share":"https://www.laohu8.com/m/news/1119138550?lang=&edition=full","pubTime":"2021-08-05 17:51","market":"us","language":"en","title":"Intel has a plan to go beyond 3nm chips","url":"https://stock-news.laohu8.com/highlight/detail?id=1119138550","media":"engadget","summary":"Its moving past nanometers, in more than one way.\n\nEarlier this year, Intel announced they were plan","content":"<blockquote>\n Its moving past nanometers, in more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> way.\n</blockquote>\n<p>Earlier this year, <a href=\"https://laohu8.com/S/INTC\">Intel</a> announced they were planning toretake the CPU manufacturing leadand \"unquestioned leadership\" in the PC world. These were impressive goals, but what was missing was any sense of how they'd actually achieve them. Now, we finally know Intel's plan.</p>\n<p>Intel's CEO Pat Gelsinger and SVP of Technology Development Dr. Ann Kelleher,laid out the company's plan for the future.For starters, Intel is renaming its manufacturing nodes. What used to be 10nm \"Enhanced Superfin\" is now just \"7.\" This may feel a little duplicitous — \"just wave a wand a you've got better technology!\" — but to be fair to intel, the nanometer measurements of process nodes don't really correspond to anything physical any more, and in terms of density Intel's current 10nm chips are competitive with TSMC and Samsung's 7nm.</p>\n<p>Looking beyond 7nm, Intel is targeting an aggressive release schedule with major product updates happening annually. We're expecting their Alder Lake chips this fall, which will mix high and low-powered cores, followed by now-4nm Meteor Lake chips that will move to a \"tile\" (chiplet) design, and incorporate Intel's <a href=\"https://laohu8.com/S/DDD\">3D</a> stacked-chip technology, Foveros.</p>\n<p>Beyond that, Intel has technology mapped out for an EUV-based 3nm node that will use the high-energy manufacturing process to streamline chip creation, and a \"20A\" for angstrom node. This is one ten-billionth of a meter (meaning it's 2nm), and will be followed by a 18A node that Intel hopes to start moving into production in 2025 for products sometime in the 2nd half of the decade. Again, while node measurements don't really correspond to physical structures any more, a silicon atom is in the area of 2 angstroms wide, so these are seriously tiny transistors.</p>\n<p>This release schedule seems aggressive, and Intel does not have the best track record of meeting targets for new nodes, but if it can even come close to these goals, expect your laptops and desktops to get a huge performance boost in the next few years.</p>","source":"lsy1628157128723","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel has a plan to go beyond 3nm chips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel has a plan to go beyond 3nm chips\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 17:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.engadget.com/intel-laid-out-an-aggressive-plan-to-build-angstrom-scale-transistors-within-the-next-five-years-180020485.html><strong>engadget</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Its moving past nanometers, in more than one way.\n\nEarlier this year, Intel announced they were planning toretake the CPU manufacturing leadand \"unquestioned leadership\" in the PC world. These were ...</p>\n\n<a href=\"https://www.engadget.com/intel-laid-out-an-aggressive-plan-to-build-angstrom-scale-transistors-within-the-next-five-years-180020485.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔","09086":"华夏纳指-U","03086":"华夏纳指"},"source_url":"https://www.engadget.com/intel-laid-out-an-aggressive-plan-to-build-angstrom-scale-transistors-within-the-next-five-years-180020485.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119138550","content_text":"Its moving past nanometers, in more than one way.\n\nEarlier this year, Intel announced they were planning toretake the CPU manufacturing leadand \"unquestioned leadership\" in the PC world. These were impressive goals, but what was missing was any sense of how they'd actually achieve them. Now, we finally know Intel's plan.\nIntel's CEO Pat Gelsinger and SVP of Technology Development Dr. Ann Kelleher,laid out the company's plan for the future.For starters, Intel is renaming its manufacturing nodes. What used to be 10nm \"Enhanced Superfin\" is now just \"7.\" This may feel a little duplicitous — \"just wave a wand a you've got better technology!\" — but to be fair to intel, the nanometer measurements of process nodes don't really correspond to anything physical any more, and in terms of density Intel's current 10nm chips are competitive with TSMC and Samsung's 7nm.\nLooking beyond 7nm, Intel is targeting an aggressive release schedule with major product updates happening annually. We're expecting their Alder Lake chips this fall, which will mix high and low-powered cores, followed by now-4nm Meteor Lake chips that will move to a \"tile\" (chiplet) design, and incorporate Intel's 3D stacked-chip technology, Foveros.\nBeyond that, Intel has technology mapped out for an EUV-based 3nm node that will use the high-energy manufacturing process to streamline chip creation, and a \"20A\" for angstrom node. This is one ten-billionth of a meter (meaning it's 2nm), and will be followed by a 18A node that Intel hopes to start moving into production in 2025 for products sometime in the 2nd half of the decade. Again, while node measurements don't really correspond to physical structures any more, a silicon atom is in the area of 2 angstroms wide, so these are seriously tiny transistors.\nThis release schedule seems aggressive, and Intel does not have the best track record of meeting targets for new nodes, but if it can even come close to these goals, expect your laptops and desktops to get a huge performance boost in the next few years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890754380,"gmtCreate":1628137045540,"gmtModify":1631891880864,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/890754380","repostId":"1158747638","repostType":4,"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873988440,"gmtCreate":1636843830814,"gmtModify":1636843830928,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Good news&nbsp;","listText":"Good news&nbsp;","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873988440","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873981731,"gmtCreate":1636843702976,"gmtModify":1636843703092,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873981731","repostId":"1129004768","repostType":4,"repost":{"id":"1129004768","kind":"news","pubTimestamp":1636764434,"share":"https://www.laohu8.com/m/news/1129004768?lang=&edition=full","pubTime":"2021-11-13 08:47","market":"us","language":"en","title":"Apple: The Bear Argument, And Why It's Wrong","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004768","media":"Seeking Alpha","summary":"Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.This may also help to explain, in part, why Apple's revenues in Greater China shot through the","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.</li>\n <li>I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.</li>\n <li>Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4bc955cc5d27328c3b89b327b9368d27\" tg-width=\"1536\" tg-height=\"1020\" width=\"100%\" height=\"auto\"><span>kmwphotography/iStock via Getty Images</span></p>\n<p>With Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.</p>\n<p>Below, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.</p>\n<p><b>Key risk #1: drop-off in demand</b></p>\n<p>Not many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's&nbsp;Pierre Ferragu&nbsp;and Satori Fund's&nbsp;Dan Niles&nbsp;are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.</p>\n<p>The first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder&nbsp;Steve Wozniak) see as merely a minor upgrade from the previous model.</p>\n<p>I see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7dc677f0a1c77dd39f40b4cc99c6fc15\" tg-width=\"460\" tg-height=\"322\" width=\"100%\" height=\"auto\"><span>Source: DM Martins Research, data from company reports</span></p>\n<p>This may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.</p>\n<p>In the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.</p>\n<p><b>Key risk #2: valuation</b></p>\n<p>The other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS&nbsp;to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.</p>\n<p>That, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.</p>\n<p>First, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer&nbsp;have been hurting social media companies&nbsp;and their financial statements&nbsp;led to the Nasdaqe&nbsp;rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0946db3f3bc62569a56f2dbe2aa75922\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Also, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.</p>\n<p><b>Key risk #3: lack of positive catalysts</b></p>\n<p>The next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and&nbsp;so has the refreshed lineup&nbsp;of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.</p>\n<p>But here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.</p>\n<p>I have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and&nbsp;autonomous vehicle&nbsp;has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.</p>\n<p><b>In summary</b></p>\n<p>Apple may not be the same pound-the-table opportunity that I believed it to be&nbsp;in February 2021&nbsp;or, better yet,in April 2018&nbsp;– in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: The Bear Argument, And Why It's Wrong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: The Bear Argument, And Why It's Wrong\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and ...</p>\n\n<a href=\"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129004768","content_text":"Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.\nMaybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.\n\nkmwphotography/iStock via Getty Images\nWith Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.\nBelow, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.\nKey risk #1: drop-off in demand\nNot many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's Pierre Ferragu and Satori Fund's Dan Niles are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.\nThe first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder Steve Wozniak) see as merely a minor upgrade from the previous model.\nI see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.\nSource: DM Martins Research, data from company reports\nThis may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.\nIn the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.\nKey risk #2: valuation\nThe other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.\nThat, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.\nFirst, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer have been hurting social media companies and their financial statements led to the Nasdaqe rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.\nData by YCharts\nAlso, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.\nKey risk #3: lack of positive catalysts\nThe next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and so has the refreshed lineup of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.\nBut here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.\nI have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and autonomous vehicle has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.\nIn summary\nApple may not be the same pound-the-table opportunity that I believed it to be in February 2021 or, better yet,in April 2018 – in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866654165,"gmtCreate":1632780229357,"gmtModify":1632797972996,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Thanks for sharing&nbsp;","listText":"Thanks for sharing&nbsp;","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866654165","repostId":"2170623235","repostType":4,"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":898982112,"gmtCreate":1628468545636,"gmtModify":1631891880806,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/898982112","repostId":"1101851851","repostType":4,"repost":{"id":"1101851851","kind":"news","pubTimestamp":1628467943,"share":"https://www.laohu8.com/m/news/1101851851?lang=&edition=full","pubTime":"2021-08-09 08:12","market":"us","language":"en","title":"Biden’s Electric-Car Ambitions Face Real-World Roadblocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1101851851","media":"The Wall Street Journal","summary":"Auto makers want congressional moves on charging stations and tax incentives; consumer support also ","content":"<p><i>Auto makers want congressional moves on charging stations and tax incentives; consumer support also is needed.</i></p>\n<p>WASHINGTON—President Biden wants to convert American motorists to electric cars as a linchpin of his plan to address&nbsp;climate change. Success heavily depends on factors outside his control.</p>\n<p>The executive order&nbsp;that Mr. Biden signed Thursday—calling on sales of electric, fuel-cell and plug-in hybrids to account for 50% of car and light truck sales by 2030—has no binding authority.</p>\n<p>Auto makers say they could meet a target of somewhere&nbsp;between 40% and 50% of sales, but only if Congress spends billions of dollars to build out a network of EV charging stations and provides tax incentives to consumers, among other measures.</p>\n<p>Beyond that,&nbsp;consumers must buy in. EVs currently account for about 3% of sales, reflecting in part generally higher upfront costs and limits on their range.</p>\n<p>“Possibly the biggest hurdle ahead is consumer acceptance,” said Jessica Caldwell, an analyst at auto-data firm Edmunds. “What will it take for Americans to be willing to change their car ownership habits to go electric?”</p>\n<p>Supporters of Mr. Biden’s plan acknowledge the magnitude of the task ahead but insist the goal is achievable.</p>\n<p>Tax incentives can help bridge the price difference between gasoline and electric vehicles at the dealership, these people say. Once purchased, electric vehicles&nbsp;offer continued savings&nbsp;in fuel and maintenance costs compared with gas vehicles, and often a better ride.</p>\n<p>A bigger national&nbsp;network of charging stations&nbsp;is also seen as key to alleviating fears of range anxiety, or running out of charge on the highway.</p>\n<p>Providing those solutions will require&nbsp;balancing a long list of interests, from industry, political parties, unions, environmentalists, regulators and local governments, among others.</p>\n<p>“That’s a Rubik’s cube of complexity,” said Larry Burns, a former GM executive and adviser to&nbsp;Alphabet&nbsp;Inc.’s&nbsp;self-driving affiliate Waymo. “And this scale is massive. So we have to have collective will to make this happen.”</p>\n<p>But Mr. Burns and others say the industry is ready to make the transition, spurred by government and international competition.</p>\n<p>Mr. Biden has made transportation a central part of his&nbsp;agenda on climate change. The sector is the country’s top source of greenhouse-gas emissions, contributing more than a quarter of the country’s planet-warming gases. And China has become a world leader in batteries and electric vehicles, a long-term threat to U.S. manufacturing.</p>\n<p>Mr. Biden’s most immediate impact will be through using the authority he does have at the Environmental Protection Agency. It is proposing new rules that would require auto makers to raise average fleetwide fuel efficiency to the equivalent of 52 miles per gallon by the 2026 model year, using an industry measure that takes both fuel efficiency and emissions reductions into account.</p>\n<p>That compares with the current requirement of 43.3 mpg for that model year under rules set last year by the Trump administration.</p>\n<p>Under the agency’s proposal, which is now subject to a public-comment period, auto makers would be allowed some increased flexibility to comply by using credits they banked in past years when they surpassed their sales goals under the fuel-efficiency requirements.</p>\n<p><i>‘There is going to be a massive dislocation...[President Biden] has to navigate through it and enforce the compromise.’</i></p>\n<p style=\"text-align:right;\"><i>— Bob Lutz, former auto executive</i></p>\n<p>That is likely to spur opposition from the left, with some environmentalists already saying the president is caving in to the auto industry. The EPA’s proposal would produce just 75% of efficiency gains that would have come from the original Obama-era rules, according to an analysis from Consumer Reports Inc., a nonprofit membership organization known for its product reviews.</p>\n<p>“There’s no doubt [the EPA proposal] is a big improvement over where we were,” said David Friedman, Consumer Reports’ vice president of advocacy. “But it doesn’t go as far as our technology can go, and both where consumers and the climate need us to go.”</p>\n<p>And the regulations themselves aren’t set in stone, said Mary Nichols, a former chairwoman of the California Air Resources Board and a pioneer of fuel-economy regulation.</p>\n<p>Mr. Biden is taking action now to toughen fuel-efficiency standards in large part because former President Donald Trump drastically relaxed standards first imposed by former President Barack Obama.</p>\n<p>“An administration that is determined to dismantle them can quickly shift course,” Ms. Nichols said.</p>\n<p>That makes Mr. Biden’s deal making with the auto makers important as an attempt to bulletproof his plan for the auto industry. The former GM executive Mr. Burns and other industry experts note that the major auto makers&nbsp;are already spending big&nbsp;to transform themselves, a major reason Mr. Biden’s plan might succeed.</p>\n<p>But it faces risks, too. Because it is voluntary, auto makers could still backtrack on their commitments, as&nbsp;they have done before. Congress has taken some of the tax credits and spending that the industry says it needs out of a pending bipartisan infrastructure package, leaving it for Democrats to consider for&nbsp;another spending billthat faces high hurdles to passage.</p>\n<p>There has been pushback from auto dealers fearful of the loss of lucrative maintenance work on traditional engines.</p>\n<p>Unions&nbsp;are fearful of job losses&nbsp;if the transition moves too quickly.</p>\n<p>Mr. Biden voiced his support for union workers throughout an event at the White House on Thursday where he signed the executive order, with executives from&nbsp;<a href=\"https://laohu8.com/S/F\">Ford</a>,&nbsp;<a href=\"https://laohu8.com/S/GM\">General Motors</a> and&nbsp;<a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> (formerly Fiat Chrysler)—all union shops—looking on.</p>\n<p>The White House left out foreign auto makers, including&nbsp;<a href=\"https://laohu8.com/S/TM\">Toyota</a>&nbsp;or&nbsp;Hyundai Motor&nbsp;Co., whose U.S. workforces aren’t union-represented, as well as&nbsp;<a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>,&nbsp;the company that has led the way in building a market for EVs.</p>\n<p>The exclusion led to a rebuke from the American International Automobile Dealers Association, which noted that any policies that “prioritize some American auto workers above others…politicize what should be a shared mission,” making reaching the EV sales target more difficult.</p>\n<p>Bob Lutz, a former senior executive at Ford, Chrysler, BMW and GM, where he was vice chairman, said Mr. Biden has now put himself at the center of what could be a messy transition process, one that will upend the status quo as auto manufacturing shifts to EV technology.</p>\n<p>“There is going to be a massive dislocation,” especially for workers, Mr. Lutz said. “He has to navigate through it and enforce the compromise. If everybody is a little unhappy but willing to accept it, that’s what he’s shooting for.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden’s Electric-Car Ambitions Face Real-World Roadblocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden’s Electric-Car Ambitions Face Real-World Roadblocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-09 08:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/bidens-electric-car-ambitions-face-real-world-roadblocks-11628427780?mod=hp_lead_pos11><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Auto makers want congressional moves on charging stations and tax incentives; consumer support also is needed.\nWASHINGTON—President Biden wants to convert American motorists to electric cars as a ...</p>\n\n<a href=\"https://www.wsj.com/articles/bidens-electric-car-ambitions-face-real-world-roadblocks-11628427780?mod=hp_lead_pos11\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STLA":"Stellantis NV","F":"福特汽车","TSLA":"特斯拉","TM":"丰田汽车","GM":"通用汽车"},"source_url":"https://www.wsj.com/articles/bidens-electric-car-ambitions-face-real-world-roadblocks-11628427780?mod=hp_lead_pos11","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101851851","content_text":"Auto makers want congressional moves on charging stations and tax incentives; consumer support also is needed.\nWASHINGTON—President Biden wants to convert American motorists to electric cars as a linchpin of his plan to address climate change. Success heavily depends on factors outside his control.\nThe executive order that Mr. Biden signed Thursday—calling on sales of electric, fuel-cell and plug-in hybrids to account for 50% of car and light truck sales by 2030—has no binding authority.\nAuto makers say they could meet a target of somewhere between 40% and 50% of sales, but only if Congress spends billions of dollars to build out a network of EV charging stations and provides tax incentives to consumers, among other measures.\nBeyond that, consumers must buy in. EVs currently account for about 3% of sales, reflecting in part generally higher upfront costs and limits on their range.\n“Possibly the biggest hurdle ahead is consumer acceptance,” said Jessica Caldwell, an analyst at auto-data firm Edmunds. “What will it take for Americans to be willing to change their car ownership habits to go electric?”\nSupporters of Mr. Biden’s plan acknowledge the magnitude of the task ahead but insist the goal is achievable.\nTax incentives can help bridge the price difference between gasoline and electric vehicles at the dealership, these people say. Once purchased, electric vehicles offer continued savings in fuel and maintenance costs compared with gas vehicles, and often a better ride.\nA bigger national network of charging stations is also seen as key to alleviating fears of range anxiety, or running out of charge on the highway.\nProviding those solutions will require balancing a long list of interests, from industry, political parties, unions, environmentalists, regulators and local governments, among others.\n“That’s a Rubik’s cube of complexity,” said Larry Burns, a former GM executive and adviser to Alphabet Inc.’s self-driving affiliate Waymo. “And this scale is massive. So we have to have collective will to make this happen.”\nBut Mr. Burns and others say the industry is ready to make the transition, spurred by government and international competition.\nMr. Biden has made transportation a central part of his agenda on climate change. The sector is the country’s top source of greenhouse-gas emissions, contributing more than a quarter of the country’s planet-warming gases. And China has become a world leader in batteries and electric vehicles, a long-term threat to U.S. manufacturing.\nMr. Biden’s most immediate impact will be through using the authority he does have at the Environmental Protection Agency. It is proposing new rules that would require auto makers to raise average fleetwide fuel efficiency to the equivalent of 52 miles per gallon by the 2026 model year, using an industry measure that takes both fuel efficiency and emissions reductions into account.\nThat compares with the current requirement of 43.3 mpg for that model year under rules set last year by the Trump administration.\nUnder the agency’s proposal, which is now subject to a public-comment period, auto makers would be allowed some increased flexibility to comply by using credits they banked in past years when they surpassed their sales goals under the fuel-efficiency requirements.\n‘There is going to be a massive dislocation...[President Biden] has to navigate through it and enforce the compromise.’\n— Bob Lutz, former auto executive\nThat is likely to spur opposition from the left, with some environmentalists already saying the president is caving in to the auto industry. The EPA’s proposal would produce just 75% of efficiency gains that would have come from the original Obama-era rules, according to an analysis from Consumer Reports Inc., a nonprofit membership organization known for its product reviews.\n“There’s no doubt [the EPA proposal] is a big improvement over where we were,” said David Friedman, Consumer Reports’ vice president of advocacy. “But it doesn’t go as far as our technology can go, and both where consumers and the climate need us to go.”\nAnd the regulations themselves aren’t set in stone, said Mary Nichols, a former chairwoman of the California Air Resources Board and a pioneer of fuel-economy regulation.\nMr. Biden is taking action now to toughen fuel-efficiency standards in large part because former President Donald Trump drastically relaxed standards first imposed by former President Barack Obama.\n“An administration that is determined to dismantle them can quickly shift course,” Ms. Nichols said.\nThat makes Mr. Biden’s deal making with the auto makers important as an attempt to bulletproof his plan for the auto industry. The former GM executive Mr. Burns and other industry experts note that the major auto makers are already spending big to transform themselves, a major reason Mr. Biden’s plan might succeed.\nBut it faces risks, too. Because it is voluntary, auto makers could still backtrack on their commitments, as they have done before. Congress has taken some of the tax credits and spending that the industry says it needs out of a pending bipartisan infrastructure package, leaving it for Democrats to consider for another spending billthat faces high hurdles to passage.\nThere has been pushback from auto dealers fearful of the loss of lucrative maintenance work on traditional engines.\nUnions are fearful of job losses if the transition moves too quickly.\nMr. Biden voiced his support for union workers throughout an event at the White House on Thursday where he signed the executive order, with executives from Ford, General Motors and Stellantis NV (formerly Fiat Chrysler)—all union shops—looking on.\nThe White House left out foreign auto makers, including Toyota or Hyundai Motor Co., whose U.S. workforces aren’t union-represented, as well as Tesla Motors, the company that has led the way in building a market for EVs.\nThe exclusion led to a rebuke from the American International Automobile Dealers Association, which noted that any policies that “prioritize some American auto workers above others…politicize what should be a shared mission,” making reaching the EV sales target more difficult.\nBob Lutz, a former senior executive at Ford, Chrysler, BMW and GM, where he was vice chairman, said Mr. Biden has now put himself at the center of what could be a messy transition process, one that will upend the status quo as auto manufacturing shifts to EV technology.\n“There is going to be a massive dislocation,” especially for workers, Mr. Lutz said. “He has to navigate through it and enforce the compromise. If everybody is a little unhappy but willing to accept it, that’s what he’s shooting for.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":602827948,"gmtCreate":1639008697068,"gmtModify":1639008697193,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Thanks for sharing&nbsp;","listText":"Thanks for sharing&nbsp;","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602827948","repostId":"1137331022","repostType":2,"repost":{"id":"1137331022","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639005672,"share":"https://www.laohu8.com/m/news/1137331022?lang=&edition=full","pubTime":"2021-12-09 07:21","market":"us","language":"zh","title":"昨夜今晨：疫苗利好再度传来！苹果续刷历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1137331022","media":"老虎资讯综合","summary":"摘要：美股三大指数小幅收涨，苹果续创历史新高；中概股多数上涨，雾芯科技收涨超21%；辉瑞公司宣布加强针疫苗可中和奥密克戎毒株；游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%>>>\n\n海外市场\n美股三大指","content":"<blockquote>\n <b>摘要：</b>美股三大指数小幅收涨，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>续创历史新高；中概股多数上涨，雾芯科技收涨超21%；<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>公司宣布加强针疫苗可中和奥密克戎毒株；<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>Q3净亏损同比扩大，盘后一度跌逾7%&gt;&gt;&gt;\n</blockquote>\n<p><b>海外市场</b></p>\n<p><b>美股三大指数小幅收涨，苹果续创收盘历史新高</b></p>\n<p>美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。</p>\n<p><b>热门中概股收盘大多走高，雾芯科技涨超21%</b></p>\n<p>中概股多数上涨，雾芯科技收涨超21%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>涨超13%，<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>涨超11%，<a href=\"https://laohu8.com/S/GOTU\">高途</a>涨超11%，<a href=\"https://laohu8.com/S/LUCKIN\">瑞幸咖啡</a>涨超9%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>涨超8%，<a href=\"https://laohu8.com/S/ZTO\">中通快递</a>涨近6%；中概新能源汽车中，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超5.8%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>涨2.1%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超1%。</p>\n<p><b>美油收高0.4%，布油上涨0.5%</b></p>\n<p>美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲<a href=\"https://laohu8.com/S/ICE\">洲际交易所</a>2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。</p>\n<p><b>黄金期货收高0.1%，并创一周来盘中最高价</b></p>\n<p>黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。</p>\n<p><b>欧股主要指数收跌，德国DAX30指数跌0.79%</b></p>\n<p>德国DAX30指数周三收跌0.79%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></a></p>\n<p>辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>摩根大通：2022年全球经济将全面复苏</b></a></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p><b>世卫组织：奥密克戎毒株将显著影响全球疫情</b></p>\n<p>世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。</p>\n<p><a href=\"https://laohu8.com/NW/2190693181\" target=\"_blank\"><b>全球芯片短缺问题未有起色，交付等待时长再创历史新高</b></a></p>\n<p>芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。</p>\n<p><a href=\"https://laohu8.com/NW/2190869550\" target=\"_blank\"><b>美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓</b></a><b></b></p>\n<p>美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>英国首相恢复居家工作建议 以遏制omicron传播</b></a></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p><b>公司新闻</b></p>\n<p><a href=\"https://laohu8.com/NW/2190931896\" target=\"_blank\"><b>苹果股价续刷历史新高，市值逼近3万亿美元</b></a></p>\n<p>周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。</p>\n<p><a href=\"https://laohu8.com/NW/1141082394\" target=\"_blank\"><b>飙涨近22%！电子烟龙头豪掷超30亿回购股票</b></a></p>\n<p>电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。</p>\n<p><a href=\"https://laohu8.com/NW/1124189543\" target=\"_blank\"><b>辉瑞：加强针疫苗可中和奥密克戎毒株</b></a></p>\n<p>辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。</p>\n<p><b><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>Evusheld疫苗获得美国食品药品监督管理局紧急使用授权</b></p>\n<p>周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。</p>\n<p><a href=\"https://laohu8.com/NW/2189667417\" target=\"_blank\"><b>谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行</b></a></p>\n<p>据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”</p>\n<p><a href=\"https://laohu8.com/NW/2189663059\" target=\"_blank\"><b>福特首款电动皮卡需求火爆，预订量接近20万辆</b></a></p>\n<p>据报道，<a href=\"https://laohu8.com/S/F\">福特汽车</a>证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。</p>\n<p><a href=\"https://laohu8.com/NW/2189527726\" target=\"_blank\"><b>英特尔CEO：供应链问题将持续至2023年</b></a></p>\n<p>英特尔和<a href=\"https://laohu8.com/S/ACN\">埃森哲</a>CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”</p>\n<p><a href=\"https://laohu8.com/NW/1131202578\" target=\"_blank\"><b>游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%</b></a></p>\n<p>财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。</p>\n<p><a href=\"https://laohu8.com/NW/1177663836\" target=\"_blank\"><b>UiPath&nbsp;2022财年第三季度净亏损同比扩大</b></a></p>\n<p>财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：疫苗利好再度传来！苹果续刷历史新高</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：疫苗利好再度传来！苹果续刷历史新高\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-09 07:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n <b>摘要：</b>美股三大指数小幅收涨，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>续创历史新高；中概股多数上涨，雾芯科技收涨超21%；<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>公司宣布加强针疫苗可中和奥密克戎毒株；<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>Q3净亏损同比扩大，盘后一度跌逾7%&gt;&gt;&gt;\n</blockquote>\n<p><b>海外市场</b></p>\n<p><b>美股三大指数小幅收涨，苹果续创收盘历史新高</b></p>\n<p>美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。</p>\n<p><b>热门中概股收盘大多走高，雾芯科技涨超21%</b></p>\n<p>中概股多数上涨，雾芯科技收涨超21%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>涨超13%，<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>涨超11%，<a href=\"https://laohu8.com/S/GOTU\">高途</a>涨超11%，<a href=\"https://laohu8.com/S/LUCKIN\">瑞幸咖啡</a>涨超9%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>涨超8%，<a href=\"https://laohu8.com/S/ZTO\">中通快递</a>涨近6%；中概新能源汽车中，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超5.8%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>涨2.1%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超1%。</p>\n<p><b>美油收高0.4%，布油上涨0.5%</b></p>\n<p>美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲<a href=\"https://laohu8.com/S/ICE\">洲际交易所</a>2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。</p>\n<p><b>黄金期货收高0.1%，并创一周来盘中最高价</b></p>\n<p>黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。</p>\n<p><b>欧股主要指数收跌，德国DAX30指数跌0.79%</b></p>\n<p>德国DAX30指数周三收跌0.79%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></a></p>\n<p>辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>摩根大通：2022年全球经济将全面复苏</b></a></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p><b>世卫组织：奥密克戎毒株将显著影响全球疫情</b></p>\n<p>世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。</p>\n<p><a href=\"https://laohu8.com/NW/2190693181\" target=\"_blank\"><b>全球芯片短缺问题未有起色，交付等待时长再创历史新高</b></a></p>\n<p>芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。</p>\n<p><a href=\"https://laohu8.com/NW/2190869550\" target=\"_blank\"><b>美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓</b></a><b></b></p>\n<p>美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>英国首相恢复居家工作建议 以遏制omicron传播</b></a></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p><b>公司新闻</b></p>\n<p><a href=\"https://laohu8.com/NW/2190931896\" target=\"_blank\"><b>苹果股价续刷历史新高，市值逼近3万亿美元</b></a></p>\n<p>周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。</p>\n<p><a href=\"https://laohu8.com/NW/1141082394\" target=\"_blank\"><b>飙涨近22%！电子烟龙头豪掷超30亿回购股票</b></a></p>\n<p>电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。</p>\n<p><a href=\"https://laohu8.com/NW/1124189543\" target=\"_blank\"><b>辉瑞：加强针疫苗可中和奥密克戎毒株</b></a></p>\n<p>辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。</p>\n<p><b><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>Evusheld疫苗获得美国食品药品监督管理局紧急使用授权</b></p>\n<p>周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。</p>\n<p><a href=\"https://laohu8.com/NW/2189667417\" target=\"_blank\"><b>谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行</b></a></p>\n<p>据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”</p>\n<p><a href=\"https://laohu8.com/NW/2189663059\" target=\"_blank\"><b>福特首款电动皮卡需求火爆，预订量接近20万辆</b></a></p>\n<p>据报道，<a href=\"https://laohu8.com/S/F\">福特汽车</a>证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。</p>\n<p><a href=\"https://laohu8.com/NW/2189527726\" target=\"_blank\"><b>英特尔CEO：供应链问题将持续至2023年</b></a></p>\n<p>英特尔和<a href=\"https://laohu8.com/S/ACN\">埃森哲</a>CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”</p>\n<p><a href=\"https://laohu8.com/NW/1131202578\" target=\"_blank\"><b>游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%</b></a></p>\n<p>财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。</p>\n<p><a href=\"https://laohu8.com/NW/1177663836\" target=\"_blank\"><b>UiPath&nbsp;2022财年第三季度净亏损同比扩大</b></a></p>\n<p>财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{"BK4501":"段永平概念","AAPL":"苹果","BK4532":"文艺复兴科技持仓",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4527":"明星科技股",".IXIC":"NASDAQ Composite","BK4534":"瑞士信贷持仓",".SPX":"S&P 500 Index","BK4507":"流媒体概念","BK4505":"高瓴资本持仓","BK4553":"喜马拉雅资本持仓","BK4554":"元宇宙及AR概念","BK4550":"红杉资本持仓","BK4559":"巴菲特持仓","BK4566":"资本集团","BK4515":"5G概念","BK4170":"电脑硬件、储存设备及电脑周边"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137331022","content_text":"摘要：美股三大指数小幅收涨，苹果续创历史新高；中概股多数上涨，雾芯科技收涨超21%；辉瑞公司宣布加强针疫苗可中和奥密克戎毒株；游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%>>>\n\n海外市场\n美股三大指数小幅收涨，苹果续创收盘历史新高\n美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。\n热门中概股收盘大多走高，雾芯科技涨超21%\n中概股多数上涨，雾芯科技收涨超21%，好未来涨超13%，贝壳涨超11%，高途涨超11%，瑞幸咖啡涨超9%，新东方涨超8%，中通快递涨近6%；中概新能源汽车中，蔚来涨超5.8%，理想汽车涨2.1%，小鹏汽车涨超1%。\n美油收高0.4%，布油上涨0.5%\n美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲洲际交易所2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。\n黄金期货收高0.1%，并创一周来盘中最高价\n黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。\n欧股主要指数收跌，德国DAX30指数跌0.79%\n德国DAX30指数周三收跌0.79%，英国富时100跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。\n国际宏观\n辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。\n摩根大通：2022年全球经济将全面复苏\n美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。\n世卫组织：奥密克戎毒株将显著影响全球疫情\n世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。\n全球芯片短缺问题未有起色，交付等待时长再创历史新高\n芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。\n美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓\n美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。\n英国首相恢复居家工作建议 以遏制omicron传播\n英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。\n公司新闻\n苹果股价续刷历史新高，市值逼近3万亿美元\n周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。\n飙涨近22%！电子烟龙头豪掷超30亿回购股票\n电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。\n辉瑞：加强针疫苗可中和奥密克戎毒株\n辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。\n阿斯利康Evusheld疫苗获得美国食品药品监督管理局紧急使用授权\n周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。\n谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行\n据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”\n福特首款电动皮卡需求火爆，预订量接近20万辆\n据报道，福特汽车证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。\n英特尔CEO：供应链问题将持续至2023年\n英特尔和埃森哲CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”\n游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%\n财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。\nUiPath 2022财年第三季度净亏损同比扩大\n财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":817943138,"gmtCreate":1630900987724,"gmtModify":1631888928550,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/817943138","repostId":"1110543090","repostType":4,"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808975375,"gmtCreate":1627554182597,"gmtModify":1631884320246,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Hope is Good","listText":"Hope is Good","text":"Hope is Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808975375","repostId":"1108176649","repostType":4,"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":605785199,"gmtCreate":1639265033810,"gmtModify":1639265033928,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"又是一个坑。看谁往里跳。","listText":"又是一个坑。看谁往里跳。","text":"又是一个坑。看谁往里跳。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605785199","repostId":"1134450838","repostType":4,"repost":{"id":"1134450838","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639148939,"share":"https://www.laohu8.com/m/news/1134450838?lang=&edition=full","pubTime":"2021-12-10 23:08","market":"us","language":"en","title":"Grab shares dropped another 9% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1134450838","media":"Tiger Newspress","summary":"Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.","content":"<p>Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/963eb8dd73ce8daa0d852d63f0bcc276\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares dropped another 9% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares dropped another 9% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 23:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/963eb8dd73ce8daa0d852d63f0bcc276\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134450838","content_text":"Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855675027,"gmtCreate":1635376050925,"gmtModify":1635377491227,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855675027","repostId":"2178234410","repostType":4,"isVote":1,"tweetType":1,"viewCount":1665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":886837710,"gmtCreate":1631579401130,"gmtModify":1631888928536,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/886837710","repostId":"1171919128","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880694514,"gmtCreate":1631053025138,"gmtModify":1631883892861,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"buy<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>","listText":"buy<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>","text":"buy$DiDi Global Inc.(DIDI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/880694514","repostId":"817455241","repostType":1,"repost":{"id":817455241,"gmtCreate":1630982859979,"gmtModify":1734394412956,"author":{"id":"3527667596890271","authorId":"3527667596890271","name":"Buy_Sell","avatar":"https://static.tigerbbs.com/a5f0ed79a338c758a22e0b4ea13bf9d2","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667596890271","authorIdStr":"3527667596890271"},"themes":[],"title":"🚀【9月7日】美股昨夜休市，港股今日高开，今天买什么？","htmlText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 9月7日讯，港股三大指数集体高开，恒指涨0.17%报26207点，国指涨0.16%报9386点，恒生科技指数涨0.52%报6814点。盘面上，国内煤炭期货开盘大涨，<a target=\"_blank\" href=\"https://laohu8.com/S/01898\">$中煤能源(01898)$</a> 高开1.75%，<a target=\"_blank\" href=\"https://laohu8.com/S/01088\">$中国神华(01088)$</a> 涨0.9%；内房股、铝业股表现强势，<a target=\"_blank\" href=\"https://laohu8.com/S/02600\">$中国铝业(02600)$</a> 涨超2%；深圳前海合作区大扩容，<a target=\"_blank\" href=\"https://laohu8.com/S/00152\">$深圳国际(00152)$</a> 涨近4%，深圳控股涨超3%；大型科技股普涨，<a target=\"_blank\" href=\"https://laohu8.com/S/03690\">$美团-W(03690)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09888\">$百度集团-SW(09888)$</a> 涨1.4%，腾讯涨1%，<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 小幅高开；生物医药下跌明显，电力","listText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 9月7日讯，港股三大指数集体高开，恒指涨0.17%报26207点，国指涨0.16%报9386点，恒生科技指数涨0.52%报6814点。盘面上，国内煤炭期货开盘大涨，<a target=\"_blank\" href=\"https://laohu8.com/S/01898\">$中煤能源(01898)$</a> 高开1.75%，<a target=\"_blank\" href=\"https://laohu8.com/S/01088\">$中国神华(01088)$</a> 涨0.9%；内房股、铝业股表现强势，<a target=\"_blank\" href=\"https://laohu8.com/S/02600\">$中国铝业(02600)$</a> 涨超2%；深圳前海合作区大扩容，<a target=\"_blank\" href=\"https://laohu8.com/S/00152\">$深圳国际(00152)$</a> 涨近4%，深圳控股涨超3%；大型科技股普涨，<a target=\"_blank\" href=\"https://laohu8.com/S/03690\">$美团-W(03690)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09888\">$百度集团-SW(09888)$</a> 涨1.4%，腾讯涨1%，<a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 、<a target=\"_blank\" href=\"https://laohu8.com/S/09618\">$京东集团-SW(09618)$</a> 小幅高开；生物医药下跌明显，电力","text":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 9月7日讯，港股三大指数集体高开，恒指涨0.17%报26207点，国指涨0.16%报9386点，恒生科技指数涨0.52%报6814点。盘面上，国内煤炭期货开盘大涨，$中煤能源(01898)$ 高开1.75%，$中国神华(01088)$ 涨0.9%；内房股、铝业股表现强势，$中国铝业(02600)$ 涨超2%；深圳前海合作区大扩容，$深圳国际(00152)$ 涨近4%，深圳控股涨超3%；大型科技股普涨，$美团-W(03690)$ 、$百度集团-SW(09888)$ 涨1.4%，腾讯涨1%，$阿里巴巴-SW(09988)$ 、$京东集团-SW(09618)$ 小幅高开；生物医药下跌明显，电力","images":[{"img":"https://static.tigerbbs.com/8eb78770aab19e4545f8e5f25ed9867a","width":"299","height":"168"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/817455241","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839290462,"gmtCreate":1629159772056,"gmtModify":1631888928564,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/839290462","repostId":"1166738043","repostType":4,"repost":{"id":"1166738043","kind":"news","pubTimestamp":1629158127,"share":"https://www.laohu8.com/m/news/1166738043?lang=&edition=full","pubTime":"2021-08-17 07:55","market":"us","language":"en","title":"Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=1166738043","media":"The Wall Street Journal","summary":"Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe","content":"<p>Early-stage study shows third dose of vaccine offers a higher level of protection, companies say</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14a5e62531f6fe58f57ee8f19db73a40\" tg-width=\"860\" tg-height=\"573\" width=\"100%\" height=\"auto\"><span>The addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.</span></p>\n<p>Pfizer&nbsp;Inc.&nbsp;and partner&nbsp;BioNTech SE&nbsp;have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.</p>\n<p>The companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.</p>\n<p>The addition of the third dose also appeared safe in the trial, the companies said.</p>\n<p>Given the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against&nbsp;symptomatic Covid-19.</p>\n<p>Pfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.</p>\n<p>The FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.</p>\n<p>Two doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.</p>\n<p>Some physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.</p>\n<p>Studies indicate the vaccine is still highly effective in people&nbsp;six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt&nbsp;he Delta variant, prompting research into adding a third dose.</p>\n<p>Last week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot&nbsp;for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.</p>\n<p>In the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.</p>\n<p>Then researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.</p>\n<p>The levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.</p>\n<p>Pfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech Seek FDA Clearance for Covid-19 Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-17 07:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a ...</p>\n\n<a href=\"https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166738043","content_text":"Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.\nPfizer Inc. and partner BioNTech SE have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.\nThe companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.\nThe addition of the third dose also appeared safe in the trial, the companies said.\nGiven the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against symptomatic Covid-19.\nPfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.\nThe FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.\nTwo doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.\nSome physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.\nStudies indicate the vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose.\nLast week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.\nIn the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.\nThen researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.\nThe levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.\nPfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897476792,"gmtCreate":1628982601416,"gmtModify":1631884932632,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Facebook(FB)$</a>like","listText":"<a href=\"https://laohu8.com/S/FB\">$Facebook(FB)$</a>like","text":"$Facebook(FB)$like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897476792","repostId":"1196685545","repostType":4,"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807859560,"gmtCreate":1628031481550,"gmtModify":1631891880878,"author":{"id":"3586332417338594","authorId":"3586332417338594","name":"YangXH","avatar":"https://static.tigerbbs.com/2da16ba61657b694381bbd12971282c6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586332417338594","authorIdStr":"3586332417338594"},"themes":[],"htmlText":"Latest up","listText":"Latest up","text":"Latest up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807859560","repostId":"1171505764","repostType":4,"isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}